ICCN Program. 17 th International Conference on. September 9-13th, Enhancing Patient Safety through Quality Cancer Nursing Practice

Transcription

1 ICCN th International Conference on Cancer Nursing Enhancing Patient Safety through Quality Cancer Nursing Practice The Premier International Educational Opportunity for Cancer Nurses Hilton Prague Hotel, Prague, Czech Republic September 9-13th, 2012 Program

2 2

3 Table of Contents Supporter Acknowledgements...7 ISNCC Leadership...8 ISNCC Full Members...9 Awards...10 General Information...13 Program at a Glance...16 Program...20 Exhibitor Information...43 About Our Supporters

4 Welcome from the ISNCC President Dear Colleagues in Cancer Nursing, On behalf of the Board of Directors of the International Society of Nurses in Cancer Care (ISNCC), I welcome you to the 17th International Conference on Cancer Nursing (ICCN), the premier international educational opportunity for cancer nurses. The theme for the 17th ICCN is Enhancing Patient Safety through Quality Cancer Nursing Practice. The ISNCC Scientific Planning Committee (SPC) and Conference Management Committee (CMC) have put together a wonderful opportunity to enhance our knowledge of professional education topics. I am also delighted to welcome you to the historical city of Prague, Czech Republic. Prague is the political, cultural and economic centre of the Czech Republic and is home to about 1.3 million people. The extensive historic centre of Prague has been included in the UNESCO list of World Heritage Sites, making the city one of the most popular tourist destinations in Europe, receiving more than 4.1 million international visitors annually. The ICCN is a wonderful opportunity to network with other cancer nurses from around the world by exchanging ideas and experiences, sharing new learnings, renewing old friendships and working in collaboration. I invite you to enjoy the unique opportunity to meet with international cancer nursing leaders from all over the world, in one place at one time. Lastly, I also invite you to continue collaborating with your international colleagues by joining ISNCC as an individual member. Please visit the ISNCC registration desk during the conference and sign up for your membership. Welcome Welcome to the 17th ICCN and the beautiful city of Prague! Dr. Greta Cummings, RN, PhD, FCAHS ISNCC President 4

5 17th ICCN Official Partners Dear Colleagues, On behalf of the European Oncology Nursing Society (EONS), an official partner of the 17th ICCN, I welcome all cancer nurses from around the world to meet in Europe, in the lovely city of Prague. It is so important that cancer nurses participate in these conferences to learn and share knowledge with each other, and discuss the best care for cancer patients. Do take this great opportunity to talk to other nurses, don t only talk with your own countrymen and women, do jump into it, and intervene and join the different discussions, sessions and workshops. And during the breaks, walk up to people and connect. Never forget that it is people who make the changes, and if there are two people talking, there is a chance for a change! So why do we attend such conferences, and discuss our profession? It is the people affected by cancer that are the reason for attending, learning, and sharing new knowledge. We must never forget that. As cancer nurses we shall lead and manage cancer care and be a strong voice in the multi professional teamwork and at the political arena. We must work together in partnership to develop, deliver and empower cancer nursing excellence through education, research, leadership and support. As EONS President I do welcome the world s cancer nurses to Europe, and hope you will enjoy your stay! Birgitte Grube, RN, MEd EONS President Dear Colleagues, As president of the Czech Nurses Association, I would like to warmly welcome you to Prague for the 17th International Conference on Cancer Nursing. The Czech Nurses Association is very happy to be an official partner of the 17th ICCN such an important event for the nursing community worldwide. Oncology diseases have an immense impact on people s lives, and only nurses who understand these issues well can effectively guide their patients and their families through the uneasy process of diagnosing and treating these diseases. Further, nurses play a crucial role in patient safety the theme of the 17th ICCN. We would like to wish you fruitful discussions in the conference sessions, and also a nice time while you discover the beauty of our capital. Dana Juraskova, MA, MBA, PhD Czech Nurses Association President Welcome from our partners 5

6 17th ICCN Official Partners Welcome from the Czech Oncology Nursing Society Dear Colleagues, Ladies and Gentlemen, Let me welcome you on behalf of the Czech Oncology Nursing Society to the 17th International Conference on Cancer Nursing (ICCN) in Prague. Our society is an official partner of ICCN and it is a great honour to us that we can organise the conference here in the Czech Republic. Czech oncology is at a very high professional and organisational level and our results are comparable with the developed countries of the European Union. We have the National Cancer Control Program which is guaranteed by the president of our Republic and the National Cancer Registry providing anonymized epidemiological data, has been functioning well for more than 20 years. The most complex and expansive care is concentrated in 13 comprehensive cancer centres which are very well equipped in all respects. Lectures on oncology are part of both pre graduate and post graduate education of doctors and nurses. Unfortunately, regarding the incidence of cancer, the Czech Republic has been occupying leading positions in Europe, for instance colorectal cancer represents a big problem. The awareness of the Czech population concerning prevention, early diagnosis and treatment of cancer is improving. We have three screening programs for early detection of breast cancer, colorectal cancer and cervical cancer. People can get all necessary information about cancer for instance on the internet pages or through a free telephone line. Welcome from our partners The Czech Oncology Nursing Society takes an active part in all above mentioned activities. Recently, the nursing care of cancer patients has improved significantly as well as the position of patients and their families. An indispensable part of nursing care is formed by quality management and patient safety which is aimed at introduction of procedures reducing the risks arising during cancer care provision. In the future, we want to improve especially prevention and early diagnosis of cancer and to expand and intensify international collaboration. This is also the target of this conference to which I cordially welcome you once more. I wish you a lot of new professional information, many new friends and also a pleasant stay in Prague. Hilda Vorlíčková, RN Czech Oncology Nursing Society President 6

7 Supporter Acknowledgements: The 17th ICCN would like to recognize the generous support of the following organizations: Symposia Preconference Workshops Marketing and Advertising Focus Groups supporters 7

8 ISNCC Leadership Leadership 8 Board of Directors President: Greta Cummings, Canada President Elect: Brenda Nevidjon, USA Secretary Treasurer: Patsy Yates, Australia Director: Catherine Johnson, Australia Director: Tish Lancaster, Australia Director: Esther Green, Canada Director: Birgitte Grube, Denmark Director: Winnie So, China Director: Yael Ben Gal, Israel Director: Linda U. Krebs, USA Conference Management Committee Chair: Esther Green, Canada Greta Cummings, Canada Patsy Yates, Australia Birgitte Grube, Denmark Erik van Muilekom, The Netherlands Cathy Glennon, USA Winnie So, China Myrna Doumit, Lebanon Corporate and Philanthropic Development Committee Chair: Esther Green, Canada Winnie So, China Catherine Johnson, Australia Annie Young, UK Brenda Nevidjon, USA Patsy Yates, Australia Connie Henke-Yarbro, USA Finance and Audit Committee Chair: Patsy Yates, Australia Candy Cooley, UK Catherine Johnson, Australia Esther Green, Canada Greta Cummings, Canada Knowledge Development and Dissemination Committee Chair: Tish Lancaster, Australia Kazuko Onishi, Japan Luz Esperanza Ayala de Calvo, Colombia Winnie So, China Catherine Johnson, Australia David Makumi, Kenya Tristan Piguet, Switzerland Birgitte Grube, Denmark Member Development and Communications Committee Chair: Catherine Johnson, Australia Kazuko Onishi, Japan Luz Esperanza Ayala de Calvo, Colombia Mary Glavassevich, Canada Mary A. Schoen, USA Andrew Dimech, UK Marlon Garzo Saria, USA Tracy L. Powell, Canada Erik van Muilekom, The Netherlands Judi Johnson, USA Wang Qi, China Emad Abu-Helal, Jordan Tish Lancaster, Australia Megan Rogers, Australia Saranchuluun Otgon, Israel Nominations and Awards Committee Chair: Sanchia Aranda, Australia Linda U. Krebs, USA Luz Esperanza Ayala de Calvo, Colombia Margaret Fitch, Canada Tish Lancaster, Australia Scientific Planning Committee Co Chair: Georgie Cusack, USA Co Chair: Iveta Valenova, Czech Republic Candy Cooley, UK Maria de Fatima Batalha, Brazil Linda U. Krebs, USA Maryanne Hargraves, Australia Klara Maxova, Czech Republic Cathy Glennon, USA Esther Green, Canada Auxilia Munodawafa, Zimbabwe

9 ISNCC Full Members Botswana Nurses Association of Botswana Kenya National Nurses Association of Kenya AFRICA Nigeria Nursing and Midwifery Council of Nigeria, University College Hospital Zimbabwe Zimbabwe Oncology Society Asia Pacific Australia India Indonesia Japan Mongolia Mongolia New Zealand People s Republic of China (PRC) Philippines Singapore South Korea Taiwan Thailand Cancer Nurses Society of Australia (CNSA) The Oncology Nurses Association of India HIMPONI/IONA Indonesian Oncology Nurses Association Japanese Society of Cancer Nursing Mongolia Nurses Association Mongolian Oncology Nursing Society Cancer Nurses Section of New Zealand Nurses Organization (NZNO) Oncology Nursing Committee of Chinese Nursing Association Philippines Oncology Nurses Association Inc. Singapore Nurses Association Korean Oncology Nursing Society (KONS) Oncology Nursing Society in Taiwan Thai International Chemotherapy Society Central and South America Brazil Chile Chile Colombia Costa Rica Guyana Panama Peru Brazilian Oncology Nursing Society (SBEO) Capitolio Chileno de Enfermeria Oncologica Ministerio de Salud La Asociación de Enfermería Oncológica Colombiana Colombian (AEOC) Asociacion Profesional del Enfermeras Oncohematologicas Guyana Cancer Registry Sociedad de Especialistas en Oncologia de Panama Sociedad Peruana De Enferenonas Encologas Europe and the middle east Algeria Bulgaria Cyprus Czech Republic Czech Republic Denmark Georgia Germany Iceland Ireland Pakistan Poland Portugal Serbia Sweden The Netherlands Turkey United Kingdom Chu Annaba, Clinique Meidcale Infantile Sainte Therese Pedi Bulgarian Oncology Nursing Society Cyprus Oncology Nursing Society Czech Nurses Association Czech Oncology Nursing Society Danish Cancer Nursing Society (FSK) Georgian Nursing Association KOK in der DKG e.v. Iceland Oncology Nursing Society Irish Association for Nurses in Oncology (IANO) Shaukat Khanum Memorial Cancer Hospital & Research Centre The Polish Oncology Nursing Society (PONS) Portuguese Oncology Nursing Association (AEOP) Oncology Nursing Section, Nurses Association of Serbia The Swedish Cancer Nurses Society The Netherlands Nursing Oncology Society (V & VN oncology) Turkish Oncology Nursing Society UK Oncology Nursing Society (UKONS) Full Members North America Canada United States Canadian Association of Nurses in Oncology (CANO/ACIO) Oncology Nursing Society (ONS) 9

10 Awards DISTINGUISHED MERIT AWARD The ISNCC Distinguished Merit Award is given in recognition of an outstanding member who has contributed to the international advancement of the science and art of cancer nursing. The awardee will be a registered nurse who has made a significant and innovative contribution to cancer practice, education, research, or management at an international level. This contribution should go beyond that which would be normally expected of a registered nurse in his/her particular sphere of professional endeavour. The successful nominee is chosen by the ISNCC Awards Committee via competition. Stella Bialous Tobacco Policy International San Francisco, USA Virginia Gumley Shaukat Khanum Memorial Cancer Hospital and Research Centre Lahore, PAKISTAN PAST PRESIDENTS AWARD The ISNCC Past Presidents Award is given in recognition of a cancer nurse from a low resource country who has initiated and sustained a program of cancer care in her/his country which has been in place for three or more years and has the potential for replication or adaptation beyond the country s borders. The successful nominee is chosen by the ISNCC Awards Committee via competition. David Makumi and Breast Health Nurses Aga Khai University Hospital Nairobi, KENYA ROBERT TIFFANY LECTURESHIP Awards The ISNCC Robert Tiffany Lectureship was created to keep alive and honour the memory of Robert Tiffany, founding member and founding President of the International Society of Nurses in Cancer Care. Robert Tiffany was the initiator of the biennial International Conference on Cancer Nursing and an inspiration to many nurses around the world. The intention of the named lecture is to honour those who have a similar capacity to inspire cancer nurses of today and of the future. The successful nominee will be a registered nurse who has the capacity to inspire others towards excellence in cancer care. They will be recognized as a leader in cancer nursing in their own country and preferably also at a regional or international level. Importantly they will be acknowledged as a person capable of delivering an inspirational lecture on a topic relevant to cancer nursing. The successful nominee is chosen by the ISNCC Awards Committee via competition. Meinir Krishnasamy Peter MacCallum Cancer Centre Victoria, AUSTRALIA 10

11 TRAVEL SCHOLARSHIPs The ISNCC Travel Scholarships are awarded to nurses from low resource countries to offset the costs associated with traveling to the International Conference on Cancer Nursing. These scholarships are chosen by the ISNCC Awards Committee via competition. Charlotte Lamptey National Centre for Radiotherapy and Nuclear Medicine, GHANA Exclusive scholarship support provided by Peter MacCallum Cancer Center Peter MacCallum Cancer Centre is a world leader in cancer treatment, research and education. At Peter Mac we treat more cancer patients each year than any other hospital and our highly skilled medical, nursing and allied health team is backed by the largest cancer research group in Australia. Peter Mac is a totally smoke-free environment. Retno Purwanti Dharmais National Cancer Centre (DNCC), INDONESIA Exclusive scholarship support provided by Princess Margaret Hospital Princess Margaret Hospital (PMH) is home to the Princess Margaret Cancer Program, which has 12 site groups and 26 specialty clinics, and almost 3,000 staff who see over 400,000 patient visits every year. Its 800,000 square feet house 130 inpatient beds, 373,000 square feet of research space and 17 radiation treatment machines, making it one of the largest comprehensive cancer treatment facilities in the world and the largest radiation treatment centre in Canada. Mesfin Anley TikurAnbessa Specialized Hospital, ETHIOPIA Exclusive scholarship support provided by Sunnybrook Health Sciences Centre Sunnybrook Health Sciences Centre in partnership with the University of Toronto, leads by discovery, innovation, teaching, & learning and is home to several programs including Brain Sciences, Musculoskeletal, Schulich Heart Centre, Trauma, Emergency and Critical Care, Veterans and Community, Women & Babies, and the Odette Cancer Centre. The Odette Cancer Centre Program is highly specialized and comprehensive, and ranks sixth in North America among a select group of world-class institutions who are research intensive, provide the full spectrum of patient care and who engage in education and community outreach. Job Wekesa Wamukaya Ampath Oncology, KENYA Exclusive scholarship support provided by MacMillan Cancer Support Macmillan Cancer Support is a charity in the United Kingdom that has been supporting people affected by cancer for more than 100 years. We provide cancer services & campaign for improvement to cancer care and patient experience. We fund health & social care professionals including nurses, doctors, therapists and information & financial advice specialists. We build information and support centres, fund self help and support groups & create volunteer run community services. We develop cancer information resources and provide support through our website and telephone support line. We collaborate with partners like the National Health Service, other charities, businesses and local government. We rely almost entirely on voluntary donations. 11 Awards

12 TRAVEL SCHOLARSHIPS Peter Kamau Kenya Methodist University, KENYA Non exclusive scholarship support provided by Cancer Nurses Society of Australia, Hunter Regional of Cancer Nurses Society of Australia, Japanese Society of Cancer Nursing, Oncology Nursing Society, and Sidney Kimmel Comprehensive The Cancer Nurses Society of Australia (CNSA) was founded in 1998 as a nursing specialist interest group as part of the Clinical Oncological Society of Australia (COSA). In 2013, CNSA will become an independent organisation for Cancer Nurses across Australia, reinforcing its position as the peak professional body for Nurses working with people affected by cancer. CNSA is committed to achieving and promoting excellence in cancer care through the professional contributions of nurses. As a membership based orgainsation CNSA has developed to support and serve Cancer Nurses in Australia. A National Executive Committee which comprises elected representatives from all States and Territories and a nationally elected President govern CNSA. Today there are 800 members throughout Australia. Cancer nurses provide services which are an integral part of an interdisciplinary approach to cancer care. The Cancer Nurses Society of Australia (CNSA) is committed to achieving and promoting excellence in cancer care through the professional contribution of nurses. The Society is dedicated to excellence in patient care, research, and education in cancer nursing. The Hunter Regional group is one of 2 groups that service the needs of Cancer Nurses in NSW. The Japanese Society of Cancer Nursing (JSCN), founded in 1987, became an organizational member of the Science Council of Japan in The JSCN aims to develop research and education, and promote the implementation of cancer nursing. As of June 2012, over 4,700 registered nurses were members of the JSCN. The board of elected directors organizes eight committees focused on publication, education/research activities, and international activities. Over 3,000 nursing professionals from diverse specialties gather at the annual conference of the JSCN. The JSCN strives to expand its international activities across Asia and around the world through collaboration with the ISNCC. The Oncology Nursing Society (ONS) is a professional association of more than 35,000 members committed to promoting excellence in oncology nursing and the transformation of cancer care. Since 1975, ONS has provided a professional community for oncology nurses, developed evidence-based education programs and treatment information, and advocated for patient care, all in an effort to improve quality of life and outcomes for patients with cancer and their families. Learn more at Awards The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins in Baltimore, Maryland is a National Cancer Institute designated comprehensive center, providing excellence in clinical care, research and education. A multidisciplinary approach assures that patients receive the highest quality of care based on the very latest scientific evidence. Laboratory research discoveries, new drug development and individualized treatments are translated into clinical care at the patients bedside. Patients and their families receive care in our medical and radiation oncology outpatient departments, our nurse-managed InPatient/ OutPatient clinics, and our specialty inpatient units for solid tumors, blood and marrow transplants, leukemia, and other hematologic malignancies. ISNCC would also like to thank its individual donors for support of the travel scholarships: Sanchia Aranda Yoko Gokan Tish Lancaster Maurene McQuestion Brenda Nevidjon Esther Ruth Schmidlin Winnie So Hiroko Tadaura Sally Whiting 12

13 General Information Venue The 17th ICCN will be held at the Hilton Prague Hotel, from September 9 13th, 2012, in the historical city of Prague, Czech Republic. ISNCC is looking forward to its 17th highly successful nursing conference the longest running international conference for our profession. HILTON PRAGUE HOTEL Pobrezni 1 Prague, Czech Republic Tel: Fax: Registration and Speaker Services Full conference registered attendees receive the following included in registration fees: Access to the welcome reception Access to all plenary and abstract sessions Access to posters and exhibits Access to conference lunch sessions, including meals Program Delegate bag Online access to the Abstract Program general information 13

14 Registration And Speaker Services Hours Date Time Saturday September 8, 2012 Sunday September 9, 2012 Monday September 10, 2012 Tuesday September 11, 2012 Wednesday September 12, 2012 Thursday September 13, :00pm 6:00pm 7:00am 7:00pm 7:00am 6:00pm 7:00am 5:30pm 7:00am 5:30pm 7:00am 12:30pm Registration is located in the Congress Hall Foyer. The Speaker Services Centre is located in room Budapest. Language The official language of the Conference is English. Mentor Program The Mentor Program provides a quality orientation for first time delegates attending the 17th ICCN. Your mentor will describe the meeting in general, how to interpret the conference program, how best to work out which sessions you would like to attend, how to benefit from the poster sessions, as well as assisting you with practical matters such as meal breaks and what to expect from social functions. More specifically, as a mentee you may be introduced to colleagues who work in similar areas of specialty. As a mentee you will be shown ways to network so that you meet new cancer nursing colleagues and contacts from around the globe. This program is designed to ensure that you have a great conference. A Meet Your Mentor session has been arranged from 5.30pm to 6.00pm on Sunday 9th September in room Paris for mentors to connect with first time attendees prior to the welcome reception. This will be hosted by members of the Member Development and Communications Committee. general information Abstract Program Oral and poster abstracts are available online only in the 17th ICCN Abstract Program. Please visit to print the 17th ICCN Abstract Program. The abstracts included in the Abstract Program have been presented as submitted by the authors. The 17th ICCN Scientific Planning Committee has not altered the submissions for inclusion. Author s credentials have been included where submitted. Exhibits and Posters The Exhibit Hall and Posters are located in the Congress Hall Foyer. Full details of all exhibitors along with a floorplan of the exhibitors can be found in this program. Posters are a wonderful educational opportunity at this conference. The Scientific Planning Committee received a wealth of abstracts on research, education, management and clinical practice, and for your convenience the posters will be profiled each day, where delegates can Meet the Authors. During these sessions, authors will be present to discuss their work with you. Posters will be individually numbered and grouped by themes within the poster hall and also within the Abstract Program (which is available to download from the ISNCC website at www. isncc.org). 14

15 Poster Move In and Move Out Hours Poster Session 1 Poster Session 2 Poster Session 3 Move In Time Presentation Hours Move Out Time Sunday September 9, :00pm 4:00pm Tuesday September 11, :00am 8:00am Wednesday September 12, :00am 8:00am Sunday September 9, pm 7.00pm Monday September 10, am 10.30am, 1.00pm 1.30pm, 3.50pm 4.20pm Tuesday September 11, am 10.50am, 1.20pm 1.50pm, 3.30pm 4.00pm Wednesday September 12, am 10.50am, 1.20pm 1.50pm, 3.30pm 4.00pm Monday September 10, :00pm 6:00pm Tuesday September 11, pm 5.30pm Wednesday September 12, pm 5.30pm Poster Topics Poster Session 1 Cancer Across Life Span Cultural and Spiritual Care Education: Nurse and Patient Ethics, Informed Consent and Clinical Trials Innovation in Practice and Roles Models of Care Delivery Politics, Policy Makers and Economics Prevention, Genetics, and Screening Quality and Patient Safety Supportive and Palliative Care Survivorship Poster Session 2 Cancer Across Life Span Cultural and Spiritual Care Education: Nurse and Patient Innovation in Practice and Roles Ethics, Informed Consent and Clinical Trials Models of Care Delivery Politics, Policy Makers and Economics Prevention, Genetics, and Screening Quality and Patient Safety Supportive and Palliative Care Survivorship Treatment Development Workforce and Healthy Workplace Issues Poster Session 3 Cultural and Spiritual Care Education: Nurse and Patient Innovation in Practice and Roles Models of Care Delivery Politics, Policy Makers and Economics Quality and Patient Safety Supportive and Palliative Care Survivorship Treatment Development Workforce and Healthy Workplace Issues Each day, awards will be given for the best poster, one for the category of Research and the other for the combined categories of Clinical Practice, Education and Leadership. A team of 2-3 judges and a coordinator will evaluate the top 10 ranked posters for each grouping based on scores given during the abstract review process. The award-winning poster will be identified with a rosette and winners will be announced at the Closing Session. The People s Choice Award is your chance to select the poster you feel is the best during each poster session. Each ICCN participant has the opportunity to take part in the selection of the daily People s Choice Award. This award can be given to any poster presented in that day s Poster Session regardless of category or topic. You will receive specially marked cards in your delegate badge that allow you to vote once each day. Votes will be tallied at the end of each day and the People s Choice Award winner s name will be announced and will receive a certificate of award at the beginning of the Plenary Session the following day. Certificates of Attendance A certificate of attendance is available in your delegate bag. Smoking Please note that although ISNCC activities will be smoke free, the Hilton Prague Hotel does offer smoking options. ISNCC believes that prevention of tobacco use, prevention of exposure to second hand smoke, assessment of nicotine dependency and support for smoking cessation are valuable approaches for nurses in order to decrease tobacco related health problems. general information 15

16 17 th International Conference on Cancer Nursing (ICCN) Program at a Glance Preconference: Friday 7 September am 5.00pm 6.00pm 8.00pm 7.00pm 9.00pm Conference Secretariat Office Open Bristol Myers Squibb Foundation Grantee Summit Welcome Reception** ISNCC Executive Committee Meeting* Preconference: Saturday 8 September am 8.00am 7.00am 6.00pm Continental Breakfast (Provided by hotel for all Hilton Prague guests) Conference Secretariat Office Open 8.00am 5.00pm Bristol Myers Squibb Foundation Grantee Summit Day 1** 8.30am 9.30pm 9.30am 5.00pm 4.00pm 6.00pm 7.00pm 9.00pm 7.00pm 9.00pm ISNCC Pre Conference Board Breakfast* ISNCC Pre Conference Board Meeting* Conference Registration and Speaker Services Open ISNCC Pre Conference Board Dinner* Bristol Myers Squibb Foundation Grantee Summit Dinner* Welcome Reception: Sunday 9 September am 8.00am 7.00am 7.00pm 7.00am 7.00pm 8.00am 12.00pm Continental Breakfast (Provided by hotel for all Hilton Prague guests) Conference Secretariat Office Open Conference Registration and Speaker Services Open ISNCC Pre Conference Board Meeting* 8.00am 5.00pm Bristol Myers Squibb Foundation Grantee Summit Day 2** 9.00am 5.00pm ISNCC Tobacco Cessation Workshop**, Supported by Bristol Myers Squibb Foundation Program-at-a-glance 9.00am 5.00pm ONS and ISNCC Pre Conference Workshop, Global Clinical Trials Awareness**, Supported by Pfizer 9.00am 5.00pm Cancer Patient Safety Framework Workshop**, Supported by Novartis 9.00am 5.00pm AVA and Bard Pre Conference Workshop*** 9.00am 5.00pm de Souza Institute Pre Conference Workshop*** 12.00pm 4.00pm Exhibitors Move In 12:00pm 4:30pm ISNCC Member Council Meeting* 3.00pm 4.00pm Poster Session 1 Move In 5.15pm 7.15pm Exhibits Open 5:30pm 6:00pm Meet Your Mentor 5.30pm 7.00pm Welcome Reception with Exhibits and Poster Session 1 16

17 Conference Day 1: Monday 10 September am 8.00am 7.00am 6.00pm 7.00am 6.00pm 7.00am 8.00am 8.00am 9.00am 9.00am 10.00am 9.45am 4.30pm Continental Breakfast (Provided by hotel for all Hilton Prague guests) Conference Secretariat Office Open Conference Registration and Speaker Services Open ISNCC Member Development and Communications Committee Meeting Official Opening Ceremony and Welcome Keynote Address Global Issues on Quality Cancer Nursing Practice to Ensure Patient Safety Exhibits Open 10.00am 10.30am Coffee/Tea Break with Exhibits and Poster Session am 11.00am 11.00am 11.50pm Distinguished Merit Award Plenary I Education 12.00pm 1.00pm Bristol Myers Squibb (BMS) Foundation Lunch Tutorial Session 1.00pm 1.30pm Coffee/Tea Break with Exhibits and Poster Session pm 2.20pm Skeletal Care Academy Lunch Tutorial Session Plenary II European Oncology Nursing Society (EONS) and ISNCC Collaborative Session Session A1 Session A2 Session A3 Session A4 Session A5 2.30pm 3.50pm Cancer Across Life Span Quality and Patient Safety Supportive and Palliative Care Prevention, Genetics, and Screening & Survivorship Education: Nurse and Patient & Supportive and Palliative Care 3.50pm 4.20pm Coffee/Tea Break with Exhibits and Poster Session 1 Session B1 Session B2 Session B3 Session B4 Session B5 4.20pm 5.40pm Innovation in Practice and Roles & Models of Care Delivery Innovation in Practice and Roles & Models of Care Delivery Prevention, Genetics, and Screening Quality and Patient Safety Models of Care Delivery 5.00pm 6.00pm 6.00pm 8.30pm Poster Session 1 Move Out Dinner Workshop hosted by Bayer* Conference Day 2: Tuesday 11 September am 8.00am Continental Breakfast (Provided by hotel for all Hilton Prague guests) 7.00am 5.30pm Conference Secretariat Office Open 7.00am 5.30pm Conference Registration and Speaker Services Open 7.00am 8.00am Poster Session 2 Move In 7.00am 8.00am ISNCC Knowledge Development and Dissemination Committee Meeting 8.00am 8.50am Plenary III Quality and Patient Safety 9.00am 10.00am ICCN Press Conference* 9.00am 10.20am ELNEC Educational Workshop 10.05am 4.15pm Exhibits Open Program-at-a-glance 17

18 Conference Day 2: Tuesday 11 September am 10.50am Coffee/Tea Break with Exhibits and Poster Session 2 Session C1 Session C2 Session C3 Session C4 Session C am 12.10pm Cultural and Spiritual Care, Prevention, Genetics and Screening & Supportive and Palliative Care Innovation in Practice and Roles & Workforce and Healthy Workplace Issues Education: Nurse and Patient, Quality and Patient Safety & Workforce and Healthy Workplace Issues Workforce and Healthy Workplace Issues Innovation in Practice and Roles 12.20pm 1.20pm Nurse Led Small Molecule Patient Education Program Lunch Session 1.20pm 1.50pm Coffee/Tea Break with Exhibits and Poster Session pm 2.40pm 2.40pm 3.30pm Plenary IV USA Oncology Nursing Society (ONS) and ISNCC Collaborative Session Robert Tiffany Lectureship 3.30pm 4.00pm Coffee/Tea Break with Exhibits and Poster Session 2 Session D1 Session D2 Session D3 Session D4 Session D5 4.00pm 5.20pm Innovation in Practice and Roles Education: Nurse and Patient & Innovation in Practice and Roles Education: Nurse and Patient Quality and Patient Safety Innovation in Practice and Roles 4.30pm 5.30pm 6.00pm 8.00pm Poster Session 2 Move Out President s Reception* Conference Day 3: Wednesday 12 September am 8.00am 7.00am 5.30pm 7.00am 5.30pm 7.00am 8.00am Continental Breakfast (Provided by hotel for all Hilton Prague guests) Conference Secretariat Office Open Conference Registration and Speaker Services Open Poster Session 3 Move In Program-at-a-glance 7.00am 8.00am 8.00am 8.50am 9.00am 10.20am 10.05am 4.15pm ISNCC Corporate and Philanthropic Development Committee Meeting Plenary V Innovation in Practice and Roles Session E1 Supportive and Palliative Care Exhibits Open Session E2 Models of Care Delivery & Survivorship Session E3 Education: Nurse and Patient 10.20am 10.50am Coffee/Tea Break with Exhibits and Poster Session 3 Session E4 Education: Nurse and Patient Session E5 Innovation in Practice and Roles, Quality and Patient Safety & Supportive and Palliative Care 18

19 Conference Day 3: Wednesday 12 September 2012 continued Session F1 Session F2 Session F3 Session F4 Session F am 12.10pm Education: Nurse and Patient & Survivorship Models of Care Delivery & Supportive and Palliative Care Education: Nurse and Patient, Prevention, Genetics and Screening & Quality and Patient Safety Quality and Patient Safety Survivorship 12.20pm 1.20pm LiveStrong Lunch Tutorial Session ICU Medical Lunch Tutorial Session 1.20pm 1.50pm Coffee/Tea Break with Exhibits and Poster Session pm 2.40pm 2.40pm 3.30pm General Business Meeting Plenary VI Workforce and Healthy Workplace Issues 3.30pm 4.00pm Coffee/Tea Break with Exhibits and Poster Session pm 5.20pm Session G1 Education: Nurse and Patient, Quality and Patient Safety, Supportive and Palliative Care & Treatment Development Session G2 Prevention, Genetics and Screening & Supportive and Palliative Care Session G3 Education: Nurse and Patient, Prevention, Genetics and Screening & Supportive and Palliative Care Session G4 Innovations in Practice and Roles & Models of Care Delivery Session G5 Innovation in Practice and Roles 4.15pm 8.30pm 4.30pm 5.30pm 5.30pm 7.30pm 8.00pm 10.00pm Exhibit Hall Tear Down Poster Session 3 Move Out Adherence Focus Group* ISNCC Board of Directors, CMC and SPC Post Conference Dinner* Conference Day 4: Thursday 13 September am 8.00am 7.00am 12.30pm 7.00am 12.30pm Continental Breakfast (Provided by hotel for all Hilton Prague guests) Conference Secretariat Office Open Conference Registration and Speaker Services Open 7.00am 8.00am ISNCC Finance and Audit Committee Meeting Tobacco Control Special Interest Group Meeting 8.00am 8.50am 9.00am 10.20am 10.20am 10.50am 10.50am 12.15pm 1.00pm 3.00pm Plenary VII Politics, Policy Makers and Economics Session H1 Cultural and Spiritual Care & Prevention, Genetics and Screening Coffee/Tea Break Closing Ceremony Session H2 Education: Nurse and Patient & Models of Care Delivery ISNCC Post Conference Board of Directors Lunch and Debrief* Session H3 Cancer Across Life- Span, Prevention, Genetics and Screening & Supportive and Palliative Care Session H4 Innovation in Practice and Roles, Models of Care Delivery & Quality and Patient Safety Program-at-a-glance 19

20 17 th International Conference on Cancer Nursing (ICCN) Program PROGRAM Preconference: Friday 7 September am 5.00pm Conference Secretariat Office Open Budapest 6.00pm 8.00pm Bristol Myers Squibb Foundation Grantee Summit Welcome Reception** Cloud 9 Restaurant 7.00pm 9.00pm ISNCC Executive Committee Meeting* Off site Preconference: Saturday 8 September am 8.00am Continental Breakfast (Provided by hotel for all Hilton Prague guests) Atrium Restaurant 7.00am 6.00pm Conference Secretariat Office Open Budapest 8.00am 5.00pm Bristol Myers Squibb Foundation Grantee Summit Day 1** Addressing Cancer Disparities in Central and Eastern Europe The aim of the Bristol Myers Squibb Foundation Grantee Summit is to provide a platform to support an audience of experienced leaders of cancer organizations from across Europe to learn from and collaborate with other leaders in addressing cancer disparities and building capacity. The conference will allow for the sharing of experiences and learnings on addressing cancer disparities via keynote presentations, educational workshops and networking activities. Faculty: Casimiro Dias, MPH, RN, Technical Officer, Human Resources for Health, WHO Regional Office for Europe, DENMARK; Patsy Yates, PhD, Professor, School of Nursing and Midwifery at Queensland University of Technology, AUSTRALIA; Virginia Gumley, BSc, RN, MA, Shaukat Khanum Memorial Cancer Hospital and Research Centre, PAKISTAN; Maria de Fátima Batalha de Menezes, RN, PhD, National Cancer Institute, BRAZIL; Katarina Lokar, RN, Institute of Oncology Ljubljana, Slovenia Nursing Society, SLOVENIA; Iwona Karwot, PhD, Lecturer and Project Leader, European Institute of Public Administration, SPAIN 8.00am 8.45am 8.45am 5.00pm Workshop Registration Workshop Sessions 8.30am 9.30pm ISNCC Pre Conference Board Breakfast* Sofia 9.30am 5.00pm ISNCC Pre Conference Board Meeting* Paris Athens & Barcelona 4.00pm 6.00pm Conference Registration Open Congress Hall Foyer Program 4.00pm 6.00pm Speaker Services Open Budapest 7.00pm 9.00pm ISNCC Pre Conference Board Dinner* Off site 7.00pm 9.00pm Bristol Myers Squibb Foundation Grantee Summit Dinner* Welcome Reception: Sunday 9 September 2012 Off site 6.00am 8.00am Continental Breakfast (Provided by hotel for all Hilton Prague guests) Atrium Restaurant 7.00am 7.00pm Conference Secretariat Office Open Budapest 20

21 Welcome Reception: Sunday 9 September 2012 continued 7.00am 7.00pm Conference Registration Open Congress Hall Foyer 7.00am 7.00pm Speaker Services Open Budapest ISNCC Pre Conference Board Meeting and Member Council Meeting* 8.00am 4.30pm 8.00am 12.00pm 12.00pm 1.00pm Board of Directors Only Lunch with Member Council Congress Hall pm 4.30pm Member Council Meeting 8.00am 5.00pm Bristol Myers Squibb Foundation Grantee Summit Day 2** Athens & Barcelona ISNCC Tobacco Cessation Workshop** Supported by Bristol Myers Squibb Foundation Tobacco Cessation Leadership Workshop for Czech Nurses The Tobacco Cessation Leadership Workshop for Czech Nurses is a program designed to: address the epidemic of tobacco use and the resulting cancers in the Czech Republic, engage nurses in the fight against tobacco and cancer prevention, and build capacity among nurses in the Czech Republic to continue working on smoking cessation and thereby cancer prevention initiatives. This workshop will be completely conducted by Nurse Champions from the Czech Republic and will include a delegate list of carefully selected Czech Republic nurses with the greatest potential for tobacco cessation and cancer prevention leadership in their home communities. 9.00am 5.00pm Madrid Faculty: Linda Sarna, DNSc, RN, FAAN, AOCN, UCLA School of Nursing, USA; Stella Aguinaga Bialous, RN, MScN, DrPH, FAAN, Tobacco Policy International, USA; Eva Kralikova, CSc, Charles University, CZECH REPUBLIC ONS and ISNCC Pre Conference Workshop, Global Clinical Trials Awareness** Supported by Pfizer ISNCC and ONS seek to educate nurses through a collaborative Clinical Trials Awareness on a Global Level Preconference Workshop at ICCN. The Clinical Trials Awareness on a Global Level Preconference Workshop is a oneday train-the-trainer program, including a workshop kit that can be used to educate nurses in delegates home communities. By the end of the Clinical Trials Awareness on a Global Level Preconference Workshop, delegates will be able to: 1. Discuss how clinical trials have contributed to major improvements in cancer treatment. 2. Describe the process of new treatment development, focusing on the components of clinical trials. 3. Describe the role and responsibilities of the direct care nurse in the care of people eligible for or enrolled in clinical trials. 4. Outline the essential content to include in patient and family education related to clinical trials. 5. Provide leadership and education about clinical trials to nurses and other healthcare professionals in their communities. Delegates who attend this preconference workshop will be expected to share the information learned with nurses in their community by providing at least one training program using the materials provided in the workshop. In addition, delegates will be asked to act as a role model in their institution and make one change in their practice. 9.00am 5.00pm Vienna Program Faculty: Barbara Lubejko, RN, MS, Project Manager/Education Team, Oncology Nursing Society, USA; Annie Young, Professor of Nursing, Warwick Medical School, UNITED KINGDOM; Elizabeth Ness, RN, MS, Nurse Consultant (Education), Center for Cancer Research, National Cancer Institute, USA 21

22 Welcome Reception: Sunday 9 September 2012 continued Cancer Patient Safety Framework Workshop** Supported by Novartis 9.00am 5.00pm Background: To date, there are more than 50 oral agents approved to fight cancer and 35% of drugs in the oncology pipeline are oral. Of these, 85% are targeted therapies. The evolution of oral targeted therapies has significantly changed the delivery and impact of cancer care. One of the challenges with oral therapies is, How do we ensure that patients receive safe and quality care that is equivalent to the care patients receive when they are treated with intravenous therapies in a controlled environment? The ISNCC Cancer Patient Safety Framework Workshop was developed to address the growing challenge of adherence to oral therapies. ICCN Preconference Workshop -- Objectives for Participants: To gain an understanding of the impact of oral therapies in oncology care; To discuss the risk factors associated with over and under adherence to therapy; and To implement tools within their practice to promote adherence. Prior to the workshop, delegates will complete online learning modules, including assessments and computer-based activities related to selected reading materials. During the workshop Nurse Champions from Czech Republic, Hungary, and Poland will present the latest research on adherence to oral therapies. (The workshop will be conducted in English with simultaneous translation to Czech, Hungarian and Polish.) Following the workshop, delegates will evaluate the potential for international synthesis and launch of an online version of the Cancer Patient Safety Framework Program for broader distribution and use by cancer nurses all over the world. By attending this workshop, oncology nurses will be equipped with the knowledge and tools to promote adherence to oral therapies, therefore improving quality of life and providing cost effective, safe, and quality care to promote positive patient outcomes. This workshop is supported by an unrestricted educational grant from Novartis. Presenters: Andrea Nečasová, Charles University Teaching Hospital, CZECH REPUBLIC; Darja Hrabánková Navrátilová, General University Hospitál, CZECH REPUBLIC; Ilona Bences, Semmelweis University, HUNGARY; Talmaci Miklósné Müller Eleonóra, Semmelweis University, HUNGARY; TBD Congress Hall 3 AVA and Bard Pre Conference Workshop*** Program 9.00am 5.00pm Enhancing Patient and Nurse Safety Through Vascular Access Best Practices This full day workshop offers participants an in-depth review of best practices for insertion, care and maintenance of peripheral, peripherally-inserted central catheters, implanted ports, and other forms of central vascular access. Planned teaching methods include didactic and practical instruction and preceptor-guided clinical simulation. Faculty are recognized leaders in vascular access, clinical experts, instructors, and mentors from a variety of U.S. practice settings. The program is planned and coordinated by the multidisciplinary Association for Vascular Access, with the support of an unrestricted educational grant from Bard Access Systems. Faculty: Pamela J. Haylock, PhD, RN, FAAN, Session Coordinator, Chief Executive Officer, Association for Vascular Access, USA, Paul L. Blackburn, RN, BSN, MNA, VA-BC, President- Elect, Association for Vascular Access, Senior Marketing Director, Clinical Education, RyMed Technologies, Inc., USA, Lois Davis, RN, MSN, VA-BC, Director of Professional Development, Association for Vascular Access, Managing Editor, Journal of the Association for Vascular Access, USA, Lorelei Papke, RN, MSN, CRNI, CEd, VA-BC, Director-at-Large, Vascular Access Certification Corporation, Clinical Nurse Manager for the Vascular Access Service Team, University of Michigan Health System, USA, Mark Rowe, RNP, MNSc, VA-BC, Director-at-Large, Association for Vascular Access, Vascular Access Specialist in the Department of Surgery, University of Arkansas for Medical Sciences (UAMS), Winthrop P. Rockefeller Cancer Institute USA, Congress Hall 2 22

23 Welcome Reception: Sunday 9 September 2012 continued de Souza Institute Pre Conference Workshop*** 9.00am 5.00pm Bringing Evidence Based Care into Oncology Nursing Practice Across Regional, National and International Boundaries the de Souza Experience Hosted by de Souza Institute Oncology nurses are a critical resource for all cancer patients and their families. However, nursing curricula do not prepare nurses to become cancer nurses with knowledge, skills and clinical judgement to meet the complex needs of the patient population. Nurses currently in the field also require evidence based knowledge and standardized approaches to support their specialized practice, and for successful management of the unique complexities in cancer care. In 2008 the Ontario Ministry of Health and Long Term Care provided funding to establish the de Souza Institute ( The key deliverable was a state of the art Institute for knowledge translation and building capacity across all domains of oncology nursing practice (generalist, specialist, advanced practice roles) with the vision to provide Ontarians with the best cancer care in the world. The de Souza Institute is leading the way in providing timely, accessible, evidence-based continuing and graduate education through innovative teaching models that incorporate online learning and telemedicine. To date, more than 3,500 nurses working along the continuum of cancer care from prevention, screening, treatment, palliation to survivorship care have participated in de Souza educational offerings and curriculum has already been sought out and delivered in other provinces, such as Alberta and in such countries as Brazil and Kuwait. The de Souza Designation- a comprehensive educational program supporting specialization of knowledge and practice of oncology nursing and directed at different levels along the trajectory of care has been launched with the goal to inspire nurses to meet the highest standard of care. This workshop is open to leaders and will provide an overview of the de Souza programs, its structure and on the new de Souza Designation. The workshop leaders will facilitate dialogue on potential partnerships with other international groups to explore opportunities for enhancing the expertise of cancer nurses, collaborating on initiatives and supporting nurses in advanced knowledge and clinical practice wherever they work. Presenters: Mary Jane Esplen, PhD, RN; Esther Green, RN, BScN, MSc (T); Sandra Li-James, BScN, MEd., CCN(C); Laura Rashleigh, RN, BScN, MScN, CON(C); Jaihui Wong, PhD; Fatima Batalha, PhD Roma 12.00pm 4.00pm Exhibitors Move In Congress Hall Foyer 3.00pm 4.00pm Poster Session 1 Move In Congress Hall Foyer 5.15pm 7.15pm Exhibits Open Congress Hall Foyer 5.30pm 6.00pm Meet Your Mentor Paris 5.30pm 7.00pm Welcome Reception with Exhibits and Poster Session 1 Come join us for a drink and snacks to celebrate the opening of the 17th ICCN! Congress Hall Foyer Conference Day 1: Monday 10 September am 8.00am Continental Breakfast (Provided by hotel for all Hilton Prague guests) Atrium Restaurant 7.00am 6.00pm Conference Secretariat Office Open Budapest 7.00am 6.00pm Conference Registration Open Congress Hall Foyer Program 7.00am 6.00pm Speaker Services Open Budapest 7.00am 8.00am ISNCC Member Development and Communications Committee Meeting Amsterdam 23

24 Conference Day 1: Monday 10 September 2012 continued Official Opening Ceremony and Welcome Chairs: Georgie Cusack, USA and Iveta Nohavová, Czech Republic 8.00am 8.15am Welcome and Greetings by Scientific Planning Committee (SPC) Co-Chairs Georgie Cusack, USA, Iveta Nohavová, CZECH REPUBLIC 8.00am 9.00am 8.15am 8.20am Greetings and Welcome Remarks from the Czech Oncology Nursing Society Hilda Vorlíčková, CZECH REPUBLIC Congress Hall am 8.30am Greetings and Welcome Remarks Video from International Council of Nurses (ICN) Greta Cummings, CANADA 8.30am 8.45am Welcome and Presidential Address Greta Cummings, CANADA 8.45am 9.00am Opening Celebration, Music by Plzeňský MLS Keynote Address 9.00am 10.00am Chairs: Georgie Cusack, USA and Iveta Nohavová, Czech Republic Global Issues on Quality Cancer Nursing Practice to Ensure Patient Safety Sultan Kav, RN, PhD, Associate Professor at Baskent University and Past President of European Oncology Nursing Society (EONS), TURKEY Congress Hall am 4.30pm Exhibits Open Congress Hall Foyer 10.00am 10.30am Coffee/Tea Break with Exhibits and Poster Session 1 Congress Hall Foyer Distinguished Merit Award Chair: Greta Cummings, Canada 10.30am 11.00am 10.30am 10.45am 10.45am 11.00am Plenary I Education Chair: Cathy Glennon, USA Tobacco Control as a Cancer Nursing Path Stella Aguinaga Bialous, President, Tobacco Policy International, USA In Ever Increasing Circles: A Cancer Nursing Journey Virginia Ann Gumley, Professor, Shaukat Khanum Memorial Cancer Hospital & Research Centre, PAKISTAN Congress Hall am 11.50pm 11.00am 11.25am Education of Oncology Patients in the Czech Republic and Slovakia Hana Svobodová, MS and Marie Zvoníčková, PhD, Professor, Charles University, CZECH REPUBLIC Congress Hall am 11.50am Oncology Nursing Education in Brazil Dalete Delalibera Correa de Faria Mota, Professor, Brazilian Society of Oncology Nursing (SBEO) and Federal University of Goiás (UFG), BRAZIL Program 24

25 Conference Day 1: Monday 10 September 2012 continued Bristol Myers Squibb Foundation Lunch Tutorial Session 12.00pm 1.00pm New Models for Elevating the Practice and Status of Community-Based Nursing Across the Spectrum of Cancer Care in Central and Eastern Europe Learning Objectives: Increase awareness of new models elevating the role of community-based nurses in providing care to cancer patients in central and eastern Europe Develop strategies for engaging nurses to help improve cancer outcomes through community-based interventions Moderators: Catharine Grimes, Director, Bristol-Myers Squibb Foundation, Birgitte Grube, President, European Oncology Nursing Society Panel: Engaging Oncology Nurses in Community-Based Prevention Strategies for Tobacco Cessation Linda Sarna, DNSc, RN, AOCN, FAAN, Professor and Lulu Wolf Hassenplug Endowed Chair, UCLA School of Nursing Utilizing General Practice Nurses to Help Improve Early Detection Rates for Pediatric Cancer Dorota Kuchna, Executive Director, Project HOPE Poland Evolving and Increasing the Role of Nurses Caring for Cancer Patients in their Communities Sarah Archer, BSN, MSN, Interim Administrative Director, Gundersen Lutheran Center for Cancer and Blood Disorders, Gundersen Lutheran Health System, La Crosse, USA Educating and Developing Oncology Nursing Leaders in Palliative Care Pam Malloy, RN, MN, FPCN, ELNEC Project Director, American Association of Colleges of Nursing Skeletal Care Academy Lunch Tutorial Session Congress Hall pm 1.00pm Managing Skeletal Complications: The Role of the Oncology Nurse During this tutorial, you will learn how to optimise the care of patients with cancer therapy-induced bone loss (CTIBL) and cancer-induced bone loss (CIBL). Key concepts will be explored in depth, and patient case studies will illustrate management strategies for the assessment and treatment of bone loss and skeletal complications. Learning objectives: Raise awareness of CTIBL and CIBL, and their impact on patient lives Describe the key principles and practices involved in the assessment of patients with bone loss Highlight nursing strategies for maintaining bone health and improving patient outcomes in cancer care 12:00pm 12:05pm 12:05pm 12:25pm 12:25pm 12:45pm 12:45pm 12:55pm 12:55pm 1:00pm Welcome and Introductions Lawrence Drudge Coates Key Concepts in the Management of Cancer Therapy Induced Bone Loss Lawrence Drudge Coates Key Concepts in the Management of Cancer Induced Bone Loss Kay Leonard Q&A Session Summary and Close Kay Leonard Congress Hall pm 1.30pm Coffee/Tea Break with Exhibits and Poster Session 1 Congress Hall Foyer Program 25

26 Conference Day 1: Monday 10 September 2012 continued Plenary II European Oncology Nursing Society (EONS) and ISNCC Collaborative Session Chair: Esther Green, Canada 1.30pm 2.20pm 2.30pm 3.50pm 2.30pm 3.50pm 1.30pm 1.55pm 1.55pm 2.20pm How Do We as Cancer Organisations Prepare Ourselves For the Future Challenges? Birgitte Grube, RN, PhD, President, European Oncology Nursing Society (EONS), DENMARK Professional Communication For Safer Cancer Care Lena Sharp, RN, PhD, Professor, Karolinska University Hospital, SWEDEN Session A1 Cancer Across Life Span Chair: Beth Ivimey, Australia 2.30pm 2.50pm 2.50pm 3.10pm 3.10pm 3.30pm 3.30pm 3.50pm Therapy Related Symptom Checklist Children: a Patient/ Parent Reported Checklist Phoebe Williams, USA Chemotherapy-Induced Menopausal Symptoms Are Timely Correlated With Ovarian Vascular Toxicity. A Prospective Study Tal Granot, ISRAEL Chemotherapy Related Symptoms and Symptom Distress of Filipino Women With Breast Cancer Loyda Amor Cajucom, PHILIPPINES Sexuality in the Aftermath of Breast and Prostate Cancer Kicki Klaeson, SWEDEN Session A2 Quality and Patient Safety Chair: Olivia Hill, Australia 2.30pm 2.50pm 2.50pm 3.10pm 3.10pm 3.30pm A Focused Ethnography Study: In Home Palliative Care Safety Issues Susanna Edwards, CANADA The Experience of Men Having Androgen Deprivation Therapy For Early Stage Prostate Cancer Karen Gorzynska, AUSTRALIA The Unmet Supportive Care Needs and Quality of Life of Patients with Cancer in Northern Taipei City Mei Bih Chen, TAIWAN Session A3 Supportive and Palliative Care Chair: Ellen Barlow, Australia Congress Hall 2 Congress Hall 1 Congress Hall pm 2.50pm Outcomes From a Web Based Education Program to Support Screening For Distress Deborah McLeod, CANADA Program 2.30pm 3.50pm 2.50pm 3.10pm 3.10pm 3.30pm 3.30pm 3.50pm Taking the Distress Out of Distress Screening Supporting Patients and Staff Simonne Simon, CANADA Assessment of Emotional Distress in Cancer Patients Undergoing Chemotherapy: A Case Study at the National Centre For Radiotherapy and Nuclear Medicine, Korle Bu Naomi Ohene Oti, GHANA Finding Balance : Developing a Psychosocial Intervention For Older Adults Who Are Bereaved After Caregiving For an Advanced Cancer Patient Lorraine Holtslander, CANADA Congress Hall 3 26

27 Conference Day 1: Monday 10 September pm 3.50pm 2.30pm 3.50pm Session A4 Prevention, Genetics, and Screening & Survivorship Chair: Winnie So, China 2.30pm 2.50pm 2.50pm 3.10pm 3.10pm 3.30pm A Genetic Family History: The Cancer Nurses Role Candy Cooley, UK Health Related Quality of Life in Head and Neck Cancer (Hnc) Patients: A Longitudinal Study Kate White, AUSTRALIA Development of a Nurse Led Survivorship Intervention for Long Term Survivors of Hodgkin Lymphoma Priscilla Gates, AUSTRALIA What Should I Eat? Evidence Based Guidelines on Nutrition 3.30pm 3.50pm and Physical Activity For Cancer Survivors Terri Ades, USA Session A5 Education: Nurse and Patient & Supportive and Palliative Care Chair: Myrna Doumit, Lebanon 2.30pm 2.50pm 2.50pm 3.10pm 3.10pm 3.30pm 3.30pm 3.50pm The Experience of Oncology Nurses in Lebanon Myrna Doumit, LEBANON Demonstration Project: Oncology Nurse Training Mariano Torres, PHILLIPINES Innovative Learning Strategy to Enhance Radiation Oncology Nursing Practice Jiahui Wong, CANADA The Taboo Topic Nurse Practitioners in Regional Victoria, Australia Regina Kendall, AUSTRALIA Athens & Barcelona Berlin & Brussels 3.50pm 4.20pm Coffee/Tea Break with Exhibits and Poster Session 1 Congress Hall Foyer 4.20pm 5.40pm 4.20pm 5.40pm Session B1 Innovation in Practice and Roles & Models of Care Delivery Chair: David Larkin, Australia 4.20pm 4.40pm 4.40pm 5.00pm 5.00pm 5.20pm Illness Suffering in Childhood Cancer: A Qualitative Interpretation of Therapeutic Conversations Shared By Nurses and Family Members Christina West, CANADA Seeing Eye to Eye: Understanding Patient s Expectation and Experiences of Follow Up in the Melanoma Clinic Jacqueline Mathieson, AUSTRALIA Ten Years and Still Going Strong Jo Ann Cryer, AUSTRALIA An Ethiopian Model of Cancer Nursing Care Delivery 5.20pm 5.40pm Mesfin Anley, ETHIOPIA Session B2 Innovation in Practice and Roles & Models of Care Delivery Chair: Pamela Malloy, USA 4.20pm 4.40pm 4.40pm 5.00pm 5.00pm 5.20pm 5.20pm 5.40pm Nurse Navigator Practice: A Time and Motion Study Andréanne Saucier and Alain Biron, CANADA Patient Navigation: How to Develop and Be a Gps (Great Patient Support System) Cynthia Cantril, USA Evaluation of Nurse Led Telephone Follow Up in Low/ Intermediate Risk Prostate Cancer Patients Mary Leahy, AUSTRALIA Evaluation of the Western Australian Cancer Nurse Coordinator Role Leanne Monterosso, AUSTRALIA Congress Hall 1 Congress Hall 2 Program 27

28 Conference Day 1: Monday 10 September 2012 continued Session B3 Prevention, Genetics and Screening Chair: Hazel Grove, South Africa 4.20pm 5.40pm 4.20pm 5.40pm 4.20pm 4.40pm 4.40pm 5.00pm 5.00pm 5.20pm 5.20pm 5.40pm Reducing Cancer Risk with Healthy Food Choices and Physical Activity Terri Ades, USA A Nurse Led Community Based and Culturally Sensitive Cancer Screening Program Mary Glavassevich and Rosemary Irish, CANADA Effectiveness of Breast Self Examination in School Girl of Eastern Part of Nepal. Kumari Rajani Deo, NEPAL Cancer Prevention Screening Education With American Indian and Alaska Native Women in the United States (Pacific Northwest): Issues and Challenges in Conducting Transcultural/ Translational Education Research C. June Strickland, USA Session B4 Quality and Patient Safety Chair: Polly Mazanec, USA 4.20pm 4.40pm 4.40pm 5.00pm 5.00pm 5.20pm 5.20pm 5.40pm How Do Cancer Patients Perceive the Quality of an Emergency Admission? An Evaluation of the Patient Experience Through the Acute Oncology Service Elaine Lennan, UK Providing High Quality Cancer Care: Achieving Person Centred Care Through Integration of Standardized Screening For Distress, the Sixth Vital Sign Margaret Fitch, CANADA Assessing Patient Satisfaction For Continuous Quality Outcome on a Medical/ Radiation Oncology Unit Eleanor Miller & Linda Ramjohn, CANADA Development of a Patient Self Report Quality of Cancer Care Index Meinir Krishnasamy, AUSTRALIA Session B5 Models of Care Delivery Chair: Keith Cox, Australia Congress Hall 3 Athens & Barcelona Program 4.20pm 5.40pm 4.20pm 4.40pm 4.40pm 5.00pm 5.00pm 5.20pm 5.20pm 5.40pm Acute Oncology Services; Developing Advanced Nurse Practitioners For Cancer Care Vicki Lewis, UK Building Partnerships With Community Institutions in Cancer Control: Nurses Leading the Way David Kinyanjui, KENYA Measuring the Outcomes of New Service Oncology Palliative Nursing Call Center Mali Kusha, ISRAEL Cancer Care Coordinator/Clinical Nurse Consultant: A Model of Advanced Practice Nursing Carla Thamm, AUSTRALIA Berlin & Brussels 5.00pm 6.00pm Poster Session 1 Move Out Congress Hall Foyer 28

29 Conference Day 1: Monday 10 September 2012 Dinner Workshop hosted by Bayer* The Care of Cancer Patients Treated with Oral Target Agents 6:00pm 6:10pm Welcome, Introductions and Objectives 6:10pm 6:25pm Introduction to solid tumors and targeted agents What is the mechanism of action of targeted agents? In which cancers treatment they are used? Which are the most common side effects (dermatological and non-dermatological)? Do we know the reasons for the side effects? Dr. Tomas Buchler 6.00pm 8.30pm 6:25pm 7:00pm Management of non-dermatological side effects (fatigue, hypertension, diarrhea) When do they usually occur and how long do they last? How can you recognize them? How do you explain them to patients? Proactive management strategy Symptomatic management Recommendations to patients Gillian Al-Kadhimi-Kings College Hospital Roma + Vienna + Madrid 7:00pm 8:00pm Management of dermatological side effects (Hand-Foot Skin Reaction & rash) When do they usually occur and how long do they last? How can you recognize them? How do you explain them to patients? Proactive management strategy Symptomatic management Recommendations to patients Catherine Markham 8:00pm 8:30pm Prepare for questions frequently asked by patients Gillian Al-Kadhimi-Kings College Hospital Conference Day 2: Tuesday 11 September am 8.00am Continental Breakfast (Provided by hotel for all Hilton Prague guests) Atrium Restaurant 7.00am 5.30pm Conference Secretariat Office Open Budapest 7.00am 5.30pm Conference Registration Open Congress Hall Foyer 7.00am 5.30pm Speaker Services Open Budapest 7.00am 8.00am Poster Session 2 Move In Congress Hall Foyer 7.00am 8.00am ISNCC Knowledge Development and Dissemination Committee Meeting Amsterdam 8.00am 8.50am Plenary III Quality and Patient Safety Chair: Maryanne Hargraves, Australia 8.00am 8.25am 8.25am 8.50am Releasing Time to Care A Case Study Wendy Wood, DBAc, MHA, BN, RN, AUSTRALIA Hospital Accreditation in Oncology in Brazil Marise Dutra Souto, Doctor in Nursing, BRAZIL 9.00am 10.00am ICCN Press Conference Roma Congress Hall 2 Program 29

30 Conference Day 2: Tuesday 11 September 2012 continued 9.00am 10.20am ELNEC Educational Workshop The Unique Role of Oncology Nurses in Palliative Care Dedicated to Educating Nurses in Excellent Palliative Care The End-of-Life Nursing Education Consortium (ELNEC) project is a national education initiative to improve palliative care. The project provides undergraduate and graduate nursing faculty, CE providers, staff development educators, specialty nurses in pediatrics, oncology, critical care and geriatrics, and other nurses with training in palliative care so they can teach this essential information to nursing students and practicing nurses. The ELNEC project is administered by the American Association of Colleges of Nursing (AACN), Washington, DC and the City of Hope, Los Angeles, CA. Objectives: At the end of this presentation, participants will be able to: Describe the unique role oncology nurses play in providing and orchestrating excellent palliative care to patients with cancer Identify at least 3 barriers in providing quality care at the end of life Define hospice and palliative care Describe the ELNEC project and the role it plays in educating oncology nurses around the world Presenters: Polly Mazanec, PhD, RN, ANP, FPCN, Assistant Professor at Francis Payne Bolton School of Nursing/Case Western Reserve, Cleveland, OH (USA), Pam Malloy, MN, RN, FPCN, ELNEC Project Director, American Association of Colleges of Nursing (AACN), Washington, DC (USA) Congress Hall am 4.15pm Exhibits Open Congress Hall Foyer 10.20am 10.50am Coffee/Tea Break with Exhibits and Poster Session 2 Congress Hall Foyer 10.50am 12.10pm Session C1 Cultural and Spiritual Care, Prevention, Genetics and Screening & Supportive and Palliative Care Chair: Candy Cooley, UK 10.50am 11.10am 11.10am 11.30am 11.30am 11.50am Caring For Adolescents With Cancer in Chinese Cultural Beliefs Li Chyun Yeh, TAIWAN Importance of Providing Tailored Resources to Patients With Metastatic Breast Cancer: Results of the Global Bridge Survey Catherine Glennon, USA Cancer Prevention, Tobacco Control and Facebook: Accounting For Gender in Cancer Nursing Research Joan Bottorff, CANADA Congress Hall am 12.10pm The First Six Months of Being Diagnosed as Advanced Lung Cancer & a Longitudinal Approach to Patients & Quality of Life Yeur Hur Lai, TAIWAN Program 10.50am 12.10pm Session C2 Innovation in Practice and Roles & Workforce and Healthy Workplace Issues Chair: Charissa Cordon, Canada 10.50am 11.10am 11.10am 11.30am Can Aerobic Laughter Therapy (Alt) Significantly Reduce Stress, Depression and Burnout of Nurses in a Hospital Setting? Bill Gee, SOUTH AFRICA The Development of Wound Cancer Clinical Nurse Specialist Through Focus Interest Group (Fig) in Dharmais National Cancer Centre Kemala Wahidi, INDONESIA Congress Hall am 11.50am Nurse Navigators Interventions and Time Requirements: Establishing a Province Wide Consensus Alain Biron and Andréanne Saucier, CANADA 30

31 Conference Day 2: Tuesday 11 September 2012 Session C3 Education: Nurse and Patient, Quality and Patient Safety & Workforce and Healthy Workplace Issues Chair: Belinda Bailey, South Africa 10.50am 11.10am Reduction in Environmental Contaminations of Cytotoxic Drugs After Multimodal Interventions Chiao Wen Huang, TAIWAN 10.50am 12.10pm 11.10am 11.30am Educational Outcomes of an Oncology Medication Safety Class Based Upon Six Sigma Methodology Tracy Gosselin, USA Congress Hall am 11.50am The Asco/Ons Chemotherapy Administration Safety Standards: A Multidisciplinary Approach to Patient Safety Kristine LeFebvre, USA 11.50am 12.10pm Teaching Chemotherapy and Biotherapy Competency For International Nurses: A Reflection on Critical Components of a Successful Education Program Jiahui Wong, CANADA Session C4 Workforce and Healthy Workplace Issues Chair: Sharon Greene, Canada 10.50am 11.10am Advancing Nursing Practice Strategy: An Overview and Evaluation Wendy Wood, Australia 10.50am 12.10pm 11.10am 11.30am 11.30am 11.50am Workplace Issues in an Oncology Hospital in Pakistan Virginia Gumley, PAKISTAN Building Nursing Capacity to Address Non Communicable Diseases: Who Recommendations Stella Bialous, USA Athens & Barcelona 11.50am 12.10pm Responding to the Cancer Challenge Sub Saharan Africa: The Experience of Forming an Interdisciplinary Team in a Newly Established Cancer Centre David Kinyanjui, KENYA Session C5 Innovation in Practice and Roles Chair: Beth Ivimey, Australia 10.50am 11.10am Preventive Effect of Electrical Acupoint Stimulation on Lower Limb Thrombosis: A Prospective Study of Elderly Patients After Malignant Gastrointestinal Tumor Surgery Lili Hou, CHINA 10.50am 12.10pm 11.10am 11.30am Overcoming Sleep Disturbances in Cancer Patients: An Innovative Pilot Study Nancy (Surya) Absolon, CANADA Berlin & Brussels 11.30am 11.50am Therapeutic Topic Use of Chamomilla Recutita in Phlebitis Due to Peripheral Intravenous Therapy Paula Elaine dos Reis, BRAZIL 11.50am 12.10pm Sexual Health, Impact of Treatment and Emotional Aspects in Women With Breast Cancer and Their Sexual Partners E Luz Bueno Robles and Virginia Inés Soto Lesmes, Colombia Program 31

32 Conference Day 2: Tuesday 11 September 2012 continued 12.20pm 1.20pm Nurse Led Small Molecule Patient Education Program Lunch Session This Lunch Session is the official launch of the online ISNCC Nurse-Led Small Molecule Chemotherapy Patient Education Program. The online program was developed to address the international need for evidence-based patient education materials that are developed and distributed by nurses and enhance both adherence and self-care capacity of patients receiving small molecule therapies. ISNCC Leaders will conduct a live demonstration of the online learning modules and patient education print materials programs. Materials on the program will be distributed during the Lunch Session and nurses will be taught to use this important resource and refer it to their colleagues. Faculty: Maryanne Hargraves, BSc, MBA, General Manager Clinical Services, Haematology and Oncology Clinics of Australia, AUSTRALIA Congress Hall pm 1.50pm Coffee/Tea Break with Exhibits and Poster Session 2 Congress Hall Foyer 1.50pm 2.40pm 2.40pm 3.30pm Plenary IV Oncology Nursing Society (ONS USA) and ISNCC Collaborative Session Chair: Greta Cummings, Canada Medication Administration Safety: Averting the Perfect Storm Mary Magee Gullatte, PhD, RN, APRN, BC, AOCN, FAAN, USA Robert Tiffany Lectureship Chair: Greta Cummings, Canada Cancer Nurses: In a World of Growing Inequity... What Now? Meinir Krishnasamy, AUSTRALIA Congress Hall 2 Congress Hall pm 4.00pm Coffee/Tea Break with Exhibits and Poster Session 2 Congress Hall Foyer Session D1 Innovation in Practice and Roles Chair: Wendy Wood, Australia 4.00pm 4.20pm Understanding Care Complexity in Ambulatory Patients With Cancer to Inform Workforce Utilisation and Optimise Patient Outcomes Meinir Krishnasamy, AUSTRALIA 4.00pm 5.20pm 4.20pm 4.40pm Implementing an Evidence-Based Risk Assessment Tool to Predict Chemotherapy-Induced Neutropenia in Breast Cancer Patients Li-Lu Chang, Taiwan Congress Hall pm 5.00pm Engaging and Involving Teenagers in Cancer Service Development; An Exemplary Model Sam Smith, UK 5.00pm 5.20pm A Case For Knowledge Translation: Using Qualitative Research Evidence to Support Smoking Cessation Among Families of Patients With Lung Cancer Joan Bottorff, CANADA Session D2 Education: Nurse and Patient & Innovation in Practice and Roles Program 4.00pm 5.20pm Chair: Job Wekesa Wamukaya, Kenya 4.00pm 4.20pm 4.20pm 4.40pm Giving Voice to the Vulnerable: Advocacy Among U.S. Oncology Nurses Pamela Haylock, USA Strengthening Oncology Nurses Voices in Ethically Difficult Situations Carol Pavlish & Katherine Brown Saltzman, USA Congress Hall pm 5.00pm Assessing the Impact of an Oncology Nursing Educational Intervention on Changes in Clinical Practice Jiahui Wong, CANADA pm 5.20pm Beyond Borders: Empowering and Inspiring Oncology Nurses in Lifelong Learning Mary Jane Esplen, CANADA

33 Conference Day 2: Tuesday 11 September 2012 Session D3 Education: Nurse and Patient Chair: Peta Samios, Australia 4.00pm 5.20pm 4.00pm 4.20pm 4.20pm 4.40pm Bridging the Gap Improved Patient Outcomes and Increased Staff Knowledge and Satisfaction Directly Attributed to the Delivery of the 16 Week Orientation Program in the Haematology / Oncology Unit At Mater Health Services in Brisbane. Jane Roach, AUSTRALIA Five Years Experience of an Australian Breast Care Nurse Practicum; A Multidisciplinary Approach to Breast Care Nurse Education & Support Elisabeth Black, AUSTRALIA Congress Hall pm 5.00pm Raising the Bar in Cancer Nursing The Launch of a New Designation in Canada Denoting Excellence Mary Jane Esplen, CANADA 5.00pm 5.20pm An Innovative Approach to Teaching Oncologic Emergencies to Nurses With Diverse Learning Styles Charissa Cordon, CANADA Session D4 Quality and Patient Safety Chair: Margaret Fitch, Canada 4.00pm 4.20pm Canadian Online Survey of Oncology Nurses; Perspectives on Patient Concerns and Considerations Regarding Treatment of Breakthrough Pain in Cancer Margaret Fitch, CANADA 4.00pm 5.20pm 4.20pm 4.40pm Nurse Led Cancer Intensive Care Outreach Management of Acutely Ill Cancer Patients Andrew Dimech, UK Athens & Barcelona 4.40pm 5.00pm Brick By Brick: Laying the Foundation For Nursing Management of Patients Receiving Intrathecal Analgesia For Refractory Cancer Pain Cindy Murphy, USA 5.00pm 5.20pm Improving Multidisciplinary Teamwork and Patient Safety in Outpatient Oncology Anne Gross, USA Session D5 Innovation in Practice and Roles Chair: Megan Rogers, Australia 4.00pm 4.20pm Improving Breast and Lung Cancer Services in Hospital Using Experience Based Co Design (Ebcd) Theresa Wiseman, UK 4.00pm 5.20pm 4.20pm 4.40pm 4.40pm 5.00pm 5.00pm 5.20pm Breast Cancer Clinical Examination Performed By Specially Educated Nurses Kirsa Kristensen & Marianne Skaarup Johansen, DENMARK Registered Nurse Flexible Sigmoidoscopy: Innovative Nursing Role to Build Capacity in Colorectal Cancer Screening Esther Green, CANADA How an Acute Oncology Service Benefits Both Patients and Trust Targets. An Evaluation One Year On Vicki Havercroft, UK Berlin & Brussels 4.30pm 5.30pm Poster Session 2 Move Out Congress Hall Foyer Program 6.00pm 8.00pm President s Reception* Cloud 9 Restaurant 33

34 Conference Day 3: Wednesday 12 September am 8.00am Continental Breakfast (Provided by hotel for all Hilton Prague guests) Atrium Restaurant 7.00am 5.30pm Conference Secretariat Office Open Budapest 7.00am 5.30pm Conference Registration Open Congress Hall Foyer 7.00am 5.30pm Speaker Services Open Budapest 7.00am 8.00am Poster Session 3 Move In Congress Hall Foyer 7.00am 8.00am ISNCC Corporate and Philanthropic Development Committee Meeting Amsterdam Plenary V Innovation in Practice and Roles Congress Hall 2 Chair: Linda Krebs, USA 8.00am 8.50am 8.00am 8.25am 8.25am 8.50am Making a Difference: Nurse Lead Services and their Contribution to Cancer Care Trish Joyce, Master of Health Science, AUSTRALIA Ensuring Young People with Cancer Have a Safe Transition into Adult Care Helen Langton, RGN, RSCN, RCNT, RNT, BA(Hons), MSc, UNITED KINGDOM Congress Hall 2 Session E1 Supportive and Palliative Care Chair: Cindy Wang (Wang, Shou Yu), Taiwan 9.00am 9.20am The Effects of Supportive Educational and Emotional Programs in Taiwanese Women With Newly Diagnosed Breast Cancer Mei Nan Liao, TAIWAN 9.00am 10.20am 9.20am 9.40am Taste and Smell Alterations Over Time in Patients With Cancer Britt Marie Bernhardsonm, SWEDEN Congress Hall am 10.00am Non Pharmacological Interventions For Cancer Related Fatigue in Men Treated For Prostate Cancer: A Systematic Review. David Larkin, AUSTRALIA 10.00am 10.20am Perceptions of Using Complementary and Alternative Medicine Among Taiwanese Women With Breast Cancer Fang Ying Chu, TAIWAN Session E2 Models of Care Delivery & Survivorship Chair: Winnie So, China 9.00am 9.20am What Impact Did the Liverpool Care Pathway Have on Four Metropolitan Melbourne Hospitals? Dianne Saward, Australia 9.00am 10.20am 9.20am 9.40am Meeting Cancer Survivorship Needs Through a Wellness Beyond Cancer Program Catherine DeGrasse, CANADA Congress Hall 2 Program 9.40am 10.00am 10.00am 10.20am Oncology Nurse s Knowledge, Belief and Role in Long Term Cancer Survivorship Metro Mn. Oncology Nursing Society (Mons) and Japan Society of Cancer Nursing (Jscn) Kazuko Onishi, JAPAN, Judi Johnson, USA Delivering Survivorship Care Catherine Glennon, USA 34

35 Conference Day 3: Wednesday 12 September 2012 Session E3 Education: Nurse and Patient Chair: Heather Ely, South Africa 9.00am 9.20am Development & Evaluation of a Breast Reconstruction Information Resource For Women Considering Breast Reconstruction Following Mastectomy Olivia Hill, AUSTRALIA 9.00am 10.20am 9.20am 9.40am Development of a Guide to Assist in The Use of the Mascc Oral Agent Teaching Tool (Moatt) Sultan Kav, TURKEY Congress Hall am 10.00am Applying psychosocial oncology practice guidelines and standards in nursing educational programs Mary Jane Esplen, CANADA 10.00am 10.20am Evidence Based Practice Guidelines For Oral Mucosa Assessment in an Acute Oncology Setting in an Academic Medical Center Regina DeGennaro, USA Session E4 Education: Nurse and Patient Chair: Annie Young, UK 9.00am 9.20am Effective Teaching and Emotional Support Can Enable Peg Tubes to Be Inserted on an Outpatient Basis Deborah Lucier, Patricia Morin and Julia Young, CANADA 9.00am 10.20am 9.00am 10.20am 9.20am 9.40am 9.40am 10.00am 10.00am 10.20am Fertility and Sexual Health Matters; The Teenager and Young Adult Cancer Population Sam Smith, UK Understanding Tumor Response When Receiving Immunological Therapies: What Do You Mean I Am Responding? My Tumor is Bigger on the Scan. Donna Gerber, USA Constipation Management in Oncology: Educational Implementation of the Constipation Risk Assessment Tool Cynthia Abarado, USA Session E5 Innovation in Practice and Roles, Quality and Patient Safety & Supportive and Palliative Care Chair: Regina Kendall, Australia 9.00am 9.20am 9.20am 9.40am 9.40am 10.00am 10.00am 10.20am An Interprofessional Workshop to Improve Collaboration and Communication in End of Life Situations Jeanne Erickson, USA Oncology Nurses and the Lived Experience of Participation in an Evidence-Based Practice Project Mary Fridman, USA Continuing Education and the Impact on Clinical Outcome Among a Group of Oncology Nurses in Ontario, Canada Massey Nematollahi, Canada Can Aerobic Laughter Therapy (Alt) Enhance Nurse Productivity and Result in Better Care? Bill Gee, SOUTH AFRICA Athens & Barcelona Berlin & Brussels 10.05am 4.15pm Exhibits Open Congress Hall Foyer 10.20am 10.50am Coffee/Tea Break with Exhibits and Poster Session 3 Congress Hall Foyer Program 35

36 Conference Day 3: Wednesday 12 September 2012 continued Session F1 Education: Nurse and Patient & Survivorship Chair: Kazuko Onishi, Japan 10.50am 11.10am Identifying Treatment Related Symptoms and Self Care Management Strategies in Adult Cancer Patients Receiving Chemotherapy and/or Radiotherapy David Larkin, AUSTRALIA 10.50am 12.10pm 11.10am 11.30am No More Sticky Notes: The Early Implementation of an Ovarian Cancer Survivorship Care Plan Carolyn Phillips, USA Congress Hall am 11.50am Cancer Patients & Self Efficacy and Perception of Self Management Support Quality in Ambulatory Care Doris Howell, CANADA 11.50am 12.10pm Awakening From the Cocoon: Family Members Transitioning Through 100 Days Post Stem Cell Transplant Daniel Gagné, CANADA Session F2 Models of Care Delivery & Supportive and Palliative Care Chair: Leanne Stone, Australia 10.50am 11.10am The Psychological Functioning of Emerging Adults Who Have a Parent With Cancer Kate White, AUSTRALIA 10.50am 12.10pm 11.10am 11.30am Supporting Children With Cancer s Coping Strategies Through Hospital Design and Philosophy of Care: An International Study Judy Rollins, USA Congress Hall am 11.50am Family Experiences of Illness Grief in Childhood Cancer: An Adaptation of the Dual Process Model of Coping With Bereavement Christina West, CANADA 11.50am 12.10pm The Long and the Short of Palliative Radiation For Bone Metastases Corsita Garraway, Canada Session F3 Education: Nurse and Patient, Prevention, Genetics and Screening & Quality and Patient Safety Chair: Lynne Dodson, UK 10.50am 11.10am The Role of the Nurse in Patient Education and Follow Up of People Receiving Oral Anti Cancer Treatment: An Australian Survey. Catherine Johnson and Kim Adler, AUSTRALIA 10.50am 12.10pm 11.10am 11.30am Media Hype to Clinical Reality: What a Cancer Nurse Needs to Know About Genetics Candy Cooley, UK Congress Hall 3 Program 11.30am 11.50am 11.50am 12.10pm Enhancing Patient Safety By Incorporating Clinical Decision Making Biases Into a New Nurse Practitioner Dennis Graham, USA Expanding the Bandwidth of Regional Collaboration: The Role of Nursing in the Implementation of Communities of Practice A. Robin Morash, CANADA 36

37 Conference Day 3: Wednesday 12 September 2012 Session F4 Quality and Patient Safety Chair: Andrew Dimech, UK 10.50am 11.10am Patient Safety: Adherence and Knowledge of Erlotinib in Lung Cancer Patients. Jean Boucher, USA 10.50am 12.10pm 11.10am 11.30am 11.30am 11.50am Improving the Quality of Distress Management: Adapting Guidelines and Algorithms For Use in Clinical Practice Doris Howell, CANADA Pressure Ulcer in Breast Cancer Hospital / National Cancer Institute Brazil Marise Souto, BRAZIL Athens & Barcelona 11.50am 12.10pm Quality, Innovation, Safety & Sustainability (Quiss): Improving the Safety of Inpatient Care Through Clinical Nurse-Initiated Audit, Evaluation and Sustainable Changes in Systems and Practice Wendy Wood, Australia Session F5 Survivorship Chair: Peta Samios, Australia 10.50am 11.10am We Deal With It Every Day That We re Here: A Qualitative Exploration of Women s Experiences of Ovarian Cancer Meridith Clare Burles, CANADA 10.50am 12.10pm 11.10am 11.30am I Feel Like A Fried Egg! A Qualitative Study of Young Cancer Survivors Experiences After Cancer Treatment May Hauken, NORWAY Berlin & Brussels 11.30am 11.50am Physical, Psychological and Social Factors of Cancer Related Fatigue Among Premenopausal Cervical Cancer Survivors Kyoko Egawa, JAPAN 11.50am 12.10pm Sexuality and Body Image Following Treatment For Early Stage Vulvar Cancer: A Qualitative Insight Ellen Barlow, AUSTRALIA LiveStrong Lunch Tutorial Session Breaking the Stigma and Silence: Training Healthcare Professionals in LMICs to Address Cancer Stigma, Myths, and Misconceptions Over the past 5 years, the Lance Armstrong Foundation has focused on understanding and addressing cancer stigma and silence through its innovative Cancer Anti-Stigma Initiative. The first initiative of its kind addressing cancer stigma on a national scale, this project was conducted in South Africa and Mexico with implementing partner John Snow Inc. (JSI), and will be rolled out in China in 2013 with new local partners. Through mass media campaigns and targeted community engagement and training, our goal is to illustrate that cancer is survivable; that cancer survivors can lead healthy, productive lives during and after cancer; and to encourage both personal and public dialogue about the disease. This session will explore this issue of cancer stigma - an issue which presents a significant barrier to providing quality care for people affected by the disease- and how training healthcare providers and empowering them to become trainers in their own communities can raise awareness, reduce impacts of stigma, and improve quality of life for patients and their families. LEARNING OBJECTIVES: Explain the concept of cancer stigma, differentiating between enacted and perceived stigmas Describe the patient perspective in dealing with cancer stigma at the individual, family and community levels through participation in an interactive module from the Lance Armstrong Foundation s Train-the-Trainer curriculum Assess the opportunity to adapt this training model for your own communities 12.20pm 1.20pm Congress Hall 1 Program Speakers: Analuisa Ramirez, Community Coordinator, Comparte tu Historia, Rebekkah Schear, Program Manager, International Programs, Lance Armstrong Foundation, Christine Claypoole, Deputy Director, International Division, John Snow, Inc. 37

38 Conference Day 3: Wednesday 12 September 2012 continued 12.20pm 1.20pm ICU Medical Lunch Tutorial Session Are you at risk for exposure to hazardous drugs? Hazardous medications are capable of causing serious effects to those exposed; including local reactions, cancer, organ toxicity, fertility problems, genetic damage, and birth defects. Regulation and guidelines for handling hazardous drugs exist, but exposures still occur. This program will examine the risk for exposure, exposure prevention, facility assessment for contamination and contamination management. Learning Objectives: Summarize recent and historical evidence for healthcare worker exposure to hazardous drugs Identify work practices that present a risk to exposure to hazardous drugs Outline interventions, including proper use of equipment and devices Describe technological advances that include CSTD that may reduce the exposure and practical considerations such as cost and ease of use when selecting a device Faculty: Seth Eisenberg, RN OCN Professional Practice Coordinator, Infusion Services, Seattle Cancer Care Alliance Congress Hall pm 1.50pm Coffee/Tea Break with Exhibits and Poster Session 3 Congress Hall Foyer 1.50pm 2.40pm General Business Meeting Congress Hall pm 3.30pm Plenary VI Workforce and Healthy Workplace Issues Chair: Georgie Cusack, USA Challenges and Opportunities of Delivering Cancer Care Services Carenx Leung, RN, MBA and Suzanne So Shan Mak, MN, BHSc, RN, HONG KONG, CHINA Congress Hall pm 4.00pm Coffee/Tea Break with Exhibits and Poster Session 3 Congress Hall Foyer 4.00pm 5.20pm Session G1 Education: Nurse and Patient, Quality and Patient Safety, Supportive and Palliative Care & Treatment Development Chair: Pongpak Pittayapan, Thailand 4.00pm 4.20pm 4.20pm 4.40pm 4.40pm 5.00pm 5.00pm 5.20pm The Effectiveness of a Family Guided Pain Management Program in Taiwanese Patients and Their Caregivers With Metastatic Cancer Pain: A Feasibility Study Sui Whi Jane, TAIWAN Management of Adverse Effects of Chemotherapy in Cancer Patients At Cancer Diseases Hospital in Lusaka, Zambia Biemba Maliti Seleji, ZAMBIA The Decision-Making Process of Targeted Therapy in Colorectal Cancer Patients Shou-Yu Wang, Taiwan Establishing an Orientation Program For Newly Diagnosed Cancer Patients in a Tertiary Care Center in a Developing Country Tayreez Mushani, KENYA Congress Hall 1 Program 38

39 Conference Day 3: Wednesday 12 September 2012 Session G2 Prevention, Genetics and Screening & Supportive and Palliative Care Chair: Job Wekesa Wamukaya, Kenya 4.00pm 4.20pm How Do Patients With Lung Cancer Experience Radiation Induced Oaesophagitis? Mary Duffy, AUSTRALIA 4.00pm 5.20pm 4.20pm 4.40pm Gender and Cancer Prevention: Getting the Right Mix For Men-Friendly Cancer Prevention Joan Bottorff, CANADA Congress Hall pm 5.00pm Patterns of Pain in Patients Receiving Colony Stimulating Factors During Chemotherapy Susan Beck, USA 5.00pm 5.20pm These Bloody Steroids, I Don t Feel Human Again Until I m Off Them & Understanding the Side Effects and Their Impact, of Steroid Therapy Associated With the Treatment of Multiple Myeloma. Kate White, AUSTRALIA Session G3 Education: Nurse and Patient, Prevention, Genetics and Screening & Supportive and Palliative Care Chair: Kazuko Onishi, Japan 4.00pm 4.20pm Adherence to Oral Anti Tumour Therapies Adherence an Unresolved Issue? Erik Aerts, SWITZERLAND 4.00pm 5.20pm 4.20pm 4.40pm Restore To Give Back What is Lost. A Unique Wellness and Supportive Care Program For Patients and Their Carers Heather Pearse, AUSTRALIA Congress Hall pm 5.00pm Factors Influencing Nurses & Behavioral Intentions Toward Providing Artificial Nutrition and Hydration to Terminal Cancer Patients: Path Analysis Li Shan Ke, TAIWAN 5.00pm 5.20pm Quality of Life and Cytokine Gene Variation in Cancer Patients and Family Caregivers Kimberly Alexander, AUSTRALIA Session G4 Innovations in Practice and Roles & Models of Care Delivery Chair: Catherine Johnson, Australia 4.00pm 5.20pm 4.00pm 4.20pm 4.20pm 4.40pm Assessment of Fitness For Chemotherapy: A Nurse Led Model of Oncogeriatric Care Alexandra McCarthy, AUSTRALIA A Novel Post Treatment Head and Neck Cancer Rehabilitation Clinic Using a Modified Version of the Distress Thermometer and Concerns Checklist Caroline Salt, UK Athens & Barcelona 4.40pm 5.00pm Development of a One on One Complementary Medicine (Cam) Decision Support Coaching Intervention For Cancer Patients and Families Tracy Truant, CANADA Program 39

40 Conference Day 3: Wednesday 12 September 2012 continued Session G5 Innovation in Practice and Roles Chair: Margaret Fitch, Canada 4.00pm 5.20pm 4.00pm 4.20pm 4.20pm 4.40pm Addressing Patient Distress Using Electronic Tools is a Phenomenon That Has Success to Improve the Patient Experience By Screening, Assessing and Intervening on Symptoms, Both Physical and Emotional That Are Burdensome to Cancer Patients Esther Green, CANADA An Important Role For Cancer Nurses: Responding to Psychosocial Distress in Cancer Patients Margaret Fitch, CANADA Berlin & Brussels 4.40pm 5.00pm An Innovative Method of Collecting Data and Communicating Research Findings to Improve Oncology Pain Management: ipad Technology Marlene Mackey, CANADA 5.00pm 5.20pm Consultation Recording Use in Oncology: Patient Benefits and Implementation Strategies Thomas Hack, CANADA 4.15pm 5.30pm Exhibitors Move Out Congress Hall Foyer 4.30pm 5.30pm Poster Session 3 Move Out Congress Hall Foyer Adherence Focus Group* 5.30pm 7.30pm This Focus Group will focus on Nursing Issues Related to Oral Therapy. We aim to obtain feedback on oral therapy to understand issues and ensure that materials have the maximum international reach. The discussion will include: adherence to oral cancer therapy, value of information on adherence, and ensuring optimum adherence with oral cancer therapy. Chair: Esther Green, RN, MSc, ISNCC Board of Directors, CANADA Roma 8.00pm 10.00pm ISNCC Board of Directors, CMC and SPC Post Conference Dinner* Off Site Restaurant Conference Day 4: Thursday 13 September am 8.00am Continental Breakfast (Provided by hotel for all Hilton Prague guests) Atrium Restaurant 7.00am 12.30pm Conference Secretariat Office Open Budapest 7.00am 12.30pm Conference Registration Open Congress Hall Foyer 7.00am 12.30pm Speaker Services Open Budapest Program 7.00am 8.00am 8.00am 8.50am ISNCC Finance and Audit Committee Meeting Tobacco Control Special Interest Group Meeting Plenary VII Politics, Policy Makers and Economics Chair: Candy Cooley, UK 8.00am 8.25am The Challenge of Personalised Care in the Current Economic Climate Shelley Dolan, UNITED KINGDOM Amsterdam Roma + Vienna + Madrid Congress Hall am 8.50am Cancer Control and Health Inequities Julia Downing, PhD, MMedSci, BN(Hons), RGN, PCTLHE, FHEA, UGANDA 40

41 Conference Day 4: Thursday 13 September 2012 Session H1 Cultural and Spiritual Care & Prevention, Genetics and Screening Chair: TBA 9.00am 9.20am Exploring the Uptake of Clinical Genetics Services in Individuals With Newly Diagnosed Colorectal Cancer Marlene Mackey, CANADA 9.00am 10.20am 9.20am 9.40am Increasing Cervical Screening Uptake: An Intervention Study in a South African Context Johanna Maree, SOUTH AFRICA Congress Hall am 10.00am Spiritual Well Being of Terminal & Ill Cancer Patients in Thailand Sureeporn Thanasilp, Thailand 10.00am 10.20am Predictive Relationships Among Breast Health Attitudes, Knowledge, and Screening Practices Among University Students in Southwest China Stoerm Anderson, Guiying Liu and Baaska Anderson, USA Session H2 Education: Nurse and Patient & Models of Care Delivery Chair: Maria de Fatima Batalha de Menezes, Brazil 9.00am 9.20am Oncology Nurse Training Programme in Ghana Uganda and Malawi and Visit to Ethiopia Lynne June Dodson, UK 9.00am 10.20am 9.20am 9.40am Developing and Pilot Testing a Patient-Led Cancer Care Website: Lessons Learnt Donna Milne, USA Congress Hall am 10.00am Educating Beyond Borders: Using E Learning as a Tool to Educate Oncology Nurses in Tanzania Margaret Hampshire and James M. Metz, USA 10.00am 10.20am Using Concept Mapping as a Teaching Learning Tool in Problem Based Cancer Nursing Education and Patient Care: a Model of Teaching For Cancer Nurses in Developing Countries Nagwa Elkateb, EGYPT Session H3 Cancer Across Life-Span, Prevention, Genetics and Screening & Supportive and Palliative Care Chair: Lene Seibæk, Denmark 9.00am 9.20am Association Between Pro Inflammatory Cytokine Genes and a Symptom Cluster of Pain, Fatigue, Sleep Disturbance, and Depression in Patients with Breast Cancer Bradley Aouizerat, USA 9.00am 10.20am 9.20am 9.40am Pregnant With Leukemia: A Tertiary Care Hospital Experience of 3 Cases Charissa Cordon, CANADA Congress Hall am 10.00am 10.00am 10.20am Quality of Life and Genetic Variants in Men With Prostate Cancer Kimberly Alexander, Australia Symptom Clusters and Health Related Quality of Life in Cholangiocarcinoma Patients Busaba Somjaivong, THAILAND Program 41

42 Conference Day 4: Thursday 13 September 2012 continued Session H4 Innovation in Practice and Roles, Models of Care Delivery & Quality and Patient Safety Chair: Cathy Glennon, USA 9.00am 9.20am 9.00am 10.20am 9.20am 9.40am 9.40am 10.00am Ambulatory Care: From Individual to Team Excellence Kathy Davison and Janice Stewart, CANADA The International Thoracic Oncology Nurse Forum Beth Ivimey, AUSTRALIA Athens & Barcelona Processes Necessary For the Safe Delivery of High Risk Medications Using Ambulatory Infusion Pumps Pamela Savage, CANADA 10.00am 10.20am 10.20am 10.50am Improved Nursing Care For Russian Cancer Patients Natalya Biryukova, RUSSIA Coffee/Tea Break Congress Hall Foyer Closing Ceremony Chair: Georgie Cusack, USA and Iveta Nohavová, Czech Republic 10.50am 11.05am 11.05am 11.20am 10.50am 12.15pm 11.20am 11.35am 11.35am 11.40am 11.40am 11.50am 11.50am 12.15pm Margaret Fitch, CANADA ISNCC Poster Awards Esther Green, CANADA Closing Speech / Address Georgie Cusack, USA and Iveta Valenova, CZECH REPUBLIC Congress Hall 2 Presentation for 18th ICCN Esther Green, CANADA President s Comments Greta Cummings, CANADA Closing Celebration Music from the Hudební smyčcové trio from Pilsen ISNCC Post Conference Board of Directors Lunch and Debrief* Atrium Restaurant Program 1.00pm 3.00pm ISNCC Past President s Award 42 * By Invitation Only

43 Exhibitor Information Congress Hall Registration Congress Hall Foyer Tabletop Exhibits Hospira Dale Medical Products BD PhaSeal desouza Institute ICU Medical Exhibit Booths Hospira Dale Medical Products BD PhaSeal de Souza Institute ICU Medical Tabletops European Oncology Nursing Society (EONS) Czech Nurses Association Oncology Nursing Society (ONS) TBD Union for International Cancer Control (UICC) Bristol Myers Squibb Foundation Bard Access Systems Amgen Multinational Association of Supportive Care in Cancer (MASCC) Cancer Nurses Society of Australia (CNSA) Exhibitor information

44 About our Supporters animal health worldwide. Bayer HealthCare has a global workforce of 55,700 employees (Dec 31, 2011) and is represented in more than 100 countries. Find more information at About our supporters Amgen discovers, develops, manufactures, and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science s promise by bringing safe, effective medicines from lab to manufacturing plant to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, bone disease, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people s lives. For more information, visit and follow us on Bard is an innovator and market leader in the design and development of innovative vascular access products offering nine product lines in more than 800 configurations meeting virtually every vascular access need. This extensive product offering is further enhanced by comprehensive clinical, educational and operational programs designed to help customers address specific challenges within their institutions and enhance patient care. Bayer HealthCare, a subgroup of Bayer AG with annual sales of EUR 17.2 billion (2011), is one of the world s leading, innovative companies in the healthcare and medical products industry and is based in Leverkusen, Germany. The company combines the global activities of the Animal Health, Consumer Care, Medical Care and Pharmaceuticals divisions. Bayer HealthCare s aim is to discover, develop, manufacture and market products that will improve human and BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people s health throughout the world. BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD s capabilities are instrumental in combating many of the world s most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 29,000 associates in approximately 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. For more information, please visit The mission of the Bristol-Myers Squibb Foundation is to help reduce health disparities by strengthening community-based health care worker capacity, integrating medical care and community-based supportive services, and mobilizing communities in the fight against disease. The Foundation engages partners to develop, execute, evaluate and promote innovative programs to improve the health outcomes of populations disproportionately affected by type 2 diabetes in the United States, China and India; HIV/AIDS in Africa; cancer in Central and Eastern Europe; hepatitis B and C in Asia; and serious mental illness in the U.S. 44

45 The Cancer Nurses Society of Australia (CNSA) was founded in 1998 as a nursing specialist interest group as part of the Clinical Oncological Society of Australia (COSA). In 2013, CNSA will become an independent organisation for Cancer Nurses across Australia, reinforcing its position as the peak professional body for Nurses working with people affected by cancer. CNSA is committed to achieving and promoting excellence in cancer care through the professional contributions of nurses. As a membership based orgainsation CNSA has developed to support and serve Cancer Nurses in Australia. A National Executive Committee which comprises elected representatives from all States and Territories and a nationally elected President govern CNSA. Today there are 800 members throughout Australia. the population, preparing tools and methods to ensure quality and safety in health care, defending professional interests, and to transform CNA into a chamber of health care professionals. Dale will demonstrate our fifth generation binder with new pre-paneled stretch materials and the postsurgical bra which offers support and compression after breast surgery. Visit us at our booth for free samples. The Czech Nurses Association is a professional, voluntary-based, nonprofit, apolitical organization with legal subjectivity. It has been established 20 years ago when then two smaller nursing organizations agreed to merge and create a bigger, stronger and united association. It is the biggest professional organization of nurses and other professional workers in the Czech Republic. The Czech Nurses Association welcomes all nurses and other non-medical professionals working in health, social or education resorts and also working in other enterprises without regards to nationality or religion. It operates across the Czech Republic. It is a member of ICN and EFN. The main objectives for the years 2011 to 2015: influencing professional education of health care professionals and supporting nursing research, strengthening the professional competencies of health care professionals and advocating for maintaining sufficient budget for health care and nursing care, anticipating and reacting to the needs of de Souza Institute is an innovative center of learning dedicated to improving cancer care by supporting excellence in oncology nursing. The Institute provides ongoing educational support, professional development and career counseling to Ontario nurses caring for patients and families dealing with cancer. Funded by the Ontario Ministry of Health and Long-Term Care, the Institute enhances nurses skills and knowledge by offering programs and workshops at no cost. Nurses work towards a de Souza Designation, the new standard in cancer care nursing. To date de Souza Institute has reached over 4000 nurses in Ontario providing cancer care and in just over four years the Institute has resulted in a 40% increase in nurses achieving specialized certification in oncology. Established in the UK in 1984, the European Oncology Nursing Society is an independent, not for profit pan- European organisation dedicated to the support and development of cancer nurses. About our supporters 45

46 With our 20,000 members we develop projects that enhance nurses skills, provide opportunities for networking and sharing of good practice, as well as raise the profile of European cancer nursing by engaging with policy development. These activities educate, support and empower cancer nurses, enabling them to provide the best possible patient care. The EONS office is based in Brussels, Avenue Mounier 83, 1200, Belgium. To learn more about our society please go to: ICU Medical is a worldwide leader in proprietary disposable medical products for vascular therapies. ICU s commitment to patient and healthcare worker safety is evident in its innovative devices and unique manufacturing systems that produce custom intravenous therapy products in record lead times. GSK Oncology is dedicated to the patients, physicians and communities pursuing the fight against cancer. At GSK Oncology, what defines us is our pledge to engage and work in concert with our communities. At GSK Oncology, our portfolio of medicines represents a heritage spanning more than five decades. Whether you are a physician, researcher, or patient, we aspire to know how GSK Oncology might engage with you in fighting the global pandemic known as cancer. The Lance Armstrong Foundation serves people affected by cancer and empowers them to take action against the world s leading cause of death. For more information, visit LIVESTRONG.org/global. About our supporters Hospira is the world s leading provider of injectable drugs and infusion technologies. Hospira offers one of the broadest portfolios of generic acute-care and oncology injectables, biosimilar medicines and integrated infusion therapy and medication management solutions. Through its products, Hospira helps improve the safety, cost and productivity of patient care. The company is headquartered in Lake Forest, Illinois, United States and has more than 14,000 employees. The head office for Hospira in Europe, Middle East and Africa is in Royal Leamington Spa, UK. Learn more about Hospira at The Multinational Association of Supportive Care in Cancer (MASCC) is an international, multidisciplinary organization with members from six continents and over fifty countries. It operates in collaboration with the International Society of Oral Oncology (ISOO). Founded in 1990, MASCC is dedicated to research and education in all areas of supportive care for patients with cancer. MASCC aims to promote professional expertise of supportive care through research and scientific exchange of ideas. Significant advances in cancer treatment have been made possible by the strides in supportive care. Because supportive care encompasses all aspects of care, it involves a variety of disciplines and specialists. Thus membership is open to all caregivers in supportive care in cancer. 46

47 Novartis provides innovative healthcare solutions that address the evolving needs of patients and societies. Headquartered in Basel, Switzerland, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, eye care, cost-saving generic pharmaceuticals, preventive vaccines and diagnostic tools, over-the-counter and animal health products. Novartis is the only global company with leading positions in these areas. In 2011, the Group achieved net sales of USD 58.6 billion, while approximately USD 9.6 billion (USD 9.2 billion excluding impairment and amortization charges) was invested in R&D throughout the Group. Novartis Group companies employ approximately 126,000 full-time-4/4. The Oncology Nursing Society (ONS) is a professional association of more than 35,000 members committed to promoting excellence in oncology nursing and the transformation of cancer care. Since 1975, ONS has provided a professional community for oncology nurses, developed evidence-based education programs and treatment information, and advocated for patient care, all in an effort to improve quality of life and outcomes for patients with cancer and their families. Learn more at UICC provides opportunities for professional development for cancer professionals, investigators, clinicians, nurses and cancer society staff and volunteers. ISNCC Cancer Patient Safety Framework Workshop There are more than 50 oral agents approved to fight cancer and 35% of drugs in the oncology pipeline are oral. Of these, 85% are targeted therapies. The evolution of oral targeted therapies has significantly changed the delivery and impact of cancer care. How do we ensure that patients receive safe and quality care that is equivalent to the care they receive when treated in a clinic or hospital environment? The ISNCC Cancer Patient Safety Framework workshop was developed to address the growing challenge of adherence to oral therapies and will allow participants to: Gain an understanding of the impact of oral therapies in oncology care; Discuss the risk factors associated with over and under adherence to therapy; Implement tools within their practice to promote adherence; and Equip themselves with the knowledge and tools to promote adherence to oral therapies >> Prior to the workshop, delegates will complete online learning modules and selected reading materials. >> During the workshop Nurse Champions from Czech Republic, Hungary, and Poland will present the latest research on adherence to oral therapies (the workshop will be conducted in English with simultaneous translation to Czech, Hungarian and Polish). >> Following the workshop, delegates will evaluate the potential for international synthesis and launch of an online version of the Cancer Patient Safety Framework Program for use by cancer nurses all over the world. The Cancer Patient Safety Framework Preconference Workshop will take place at 9.00am 5.00pm on Sunday, September 9, 2012 in Congress Hall 3 at the Hilton Prague Hotel, Czech Republic. If you are interested in attending this exciting program, please info@isncc.org. We look forward to seeing you in Prague! This workshop is supported by an unrestricted educational grant from Novartis. Online version coming soon!

48 The Many Dimensions of Safety VISIT US IN THE EXHIBIT ALLEY Rubik s Cube used by permission of Seven Towns Ltd. BD PhaSeal Closed drug transfer from vial to patient The BD PhaSeal closed-system drug transfer device builds on two unique features: its double membrane technology, which creates a dry, leakproof connection and its airtight expansion chamber, which contains all aerosols, particles and vapours as well as equalizes the pressure in the vial. With BD PhaSeal, your safety is never compromised. To help maximize that safety, we have designed BD PhaSeal to both operate simply and fit easily within your existing oncology healthcare procedures. For more information on BD PhaSeal, visit us in the exhibit alley during the ICCN event, or at PhaSeal.com Scan this code with your phone or tablet BD, BD Logo and BD PhaSeal are trademarks of Becton, Dickinson and Company. MED BD BD Medical The Danby Building Edmund Halley Road Oxford Science Park Oxford OX4 4DQ Carmel Pharma AB Aminogatan 30 SE Mölndal SWEDEN